Processing 00000000.tx.1: Mutation of Active Site Residues of Insulin-degrading Enzyme Alters Allosteric Interactions* Eun Suk Song, Abigail Daily, Michael G. 

Phrase: "Mutation of Active Site Residues of Insulin-degrading Enzyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0026882:Mutation [Genetic Function]
   742   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "Alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "Allosteric Interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "* Eun Suk Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0872005:Song [Intellectual Product]

Phrase: "Abigail Daily,"

Phrase: "Michael G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.2: Fried, Maria Aparecida Juliano, Luiz Juliano, and Louis B. 

Phrase: "Fried"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1825319:FRY [Gene or Genome]

Phrase: ","

Phrase: "Maria Aparecida Juliano,"

Phrase: "Luiz Juliano,"

Phrase: "and"

Phrase: "Louis B."
Processing 00000000.tx.3: Hersh From the Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, Kentucky 40536 and the Department of Biophysics, Escola Paulista de Medicina, Sao Paulo 04023-900, Brazil Received for publication, February 18, 2005  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  The active site glutamate (Glu111) and the active site histidine (His112) of insulin-degrading enzyme (IDE) were mutated. 

Phrase: "Hersh From the Department of Molecular"

Phrase: "and"

Phrase: "Cellular Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "University of Kentucky,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022557:Kentucky [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Lexington,"

Phrase: "Kentucky 40536"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022557:Kentucky [Geographic Area]

Phrase: "and"

Phrase: "the Department of Biophysics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "Escola Paulista de Medicina,"

Phrase: "Sao Paulo 04023-900,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1862323:SAO [Gene or Genome]

Phrase: "Brazil"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006137:Brazil [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "February 18,"

Phrase: "2005  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The active site glutamate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   827   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0205681:Active Site [Functional Concept]

Phrase: "(Glu111"

Phrase: ")"

Phrase: "and"

Phrase: "the active site histidine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0019602:Histidine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C0205681:Active Site [Functional Concept]

Phrase: "(His112"

Phrase: ")"

Phrase: "of insulin-degrading enzyme (IDE)"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "mutated."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]
Processing 00000000.tx.4: These mutant enzymes exhibit, in addition to a large decrease in catalytic activity, a change in the substrate-velocity response from a sigmoidal one seen with the native enzyme (Hill coefficient > 2), to a hyperbolic response. 

Phrase: "These mutant enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: ","

Phrase: "in addition to a large decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392756:Decrease [Qualitative Concept]
   861   C0547047:Decrease [Quantitative Concept]

Phrase: "in catalytic activity,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0243102:catalytic activity [Molecular Function]
  1000   C1264638:Catalytic activity [Functional Concept]
  1000   C1547012:*Catalytic Activity [Quantitative Concept]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "a change in the substrate-velocity response"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0392747:Change [Functional Concept]
   748   C0443172:change [Quantitative Concept]
   748   C1705241:Change [Quantitative Concept]

Phrase: "from a sigmoidal one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "seen with the native enzyme"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0205397:Seen [Qualitative Concept]
   760   C0302891:Native [Functional Concept]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "(Hill coefficient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0442532:Hill [Spatial Concept]
   861   C1707429:*Coefficient [Quantitative Concept]

Phrase: "> 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "to a hyperbolic response."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]
Processing 00000000.tx.5: With 2-aminobenzoyl-GGFLRKHGQ-N-(2,4-dinitrophenyl)ethylenediamine as substrate, ATP and triphosphate increase the reaction rate of the wild type enzyme some 5080-fold. 

Phrase: "With 2-aminobenzoyl-GGFLRKHGQ-N-(2,4-dinitrophenyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "ethylenediamine as substrate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0015091:Ethylenediamine [Organic Chemical,Pharmacologic Substance]

Phrase: "ATP"

Phrase: "and"

Phrase: "triphosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0146894:triphosphate [Inorganic Chemical]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the reaction rate of the wild type enzyme"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0678608:reaction rate [Temporal Concept]
   744   C0443286:Reaction [Functional Concept]
   744   C0871208:Rate [Activity]
   744   C1114821:Reaction [Clinical Attribute]
   744   C1521828:Rate [Quantitative Concept]

Phrase: "some 5080-fold."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]
Processing 00000000.tx.6: This effect is dampened with glutamate mutants to no effect or less than a 3-fold increase in activity and changed to inhibition with the histidine mutants. 

Phrase: "This effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "dampened with glutamate mutants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   770   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "to no effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "less than a 3-fold increase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0439092:Less Than [Intellectual Product]
           less
   753   C0332462:Fold [Spatial Concept]
   753   C0442805:Increase [Functional Concept]
   753   C0547044:Less [Qualitative Concept]
   753   C1880834:FOLD [Phenomenon or Process]

Phrase: "in activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "changed to inhibition"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C0392747:Changed [Functional Concept]
   790   C0443172:Changed [Quantitative Concept]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C3463820:Inhibition [Activity]
   756 E C1705241:Change [Quantitative Concept]
   718 E C0311403:Inhibited [Qualitative Concept]

Phrase: "with the histidine mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.7: Sedimentation equilibrium shows the IDE mutants exhibit a similar oligomeric distribution as the wild type enzyme, being predominantly monomeric, with triphosphate having little if any effect on the oligomeric state. 

Phrase: "Sedimentation equilibrium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0597429:sedimentation equilibrium [Natural Phenomenon or Process]
   861   C0014653:Equilibrium [Organism Function]
   861   C1547026:Equilibrium [Quantitative Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the IDE mutants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0596988:mutants [Cell or Molecular Dysfunction]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a similar oligomeric distribution as the wild type enzyme,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0520511:distribution [Idea or Concept]
   742   C1704711:Distribution [Functional Concept]

Phrase: "being"

Phrase: "predominantly monomeric,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "with triphosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0146894:triphosphate [Inorganic Chemical]

Phrase: "having"

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "if"

Phrase: "any effect on the oligomeric state."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.8: Triphosphate did induce aggregation of many of the IDE mutants. 

Phrase: "Triphosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0146894:triphosphate [Inorganic Chemical]

Phrase: "did"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "aggregation of many of the IDE mutants."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332621:Aggregation [Functional Concept]
   742   C0439168:% aggregation [Quantitative Concept]
Processing 00000000.tx.9: Thus, the oligomeric state of IDE does not correlate with kinetic properties. 

Phrase: "Thus,"

Phrase: "the oligomeric state of IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1301808:State [Geographic Area]
   748   C1442792:State [Functional Concept]
   748   C3148680:State [Geographic Area]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "correlate with kinetic properties."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0022702:kinetic [Natural Phenomenon or Process]
   770   C0871161:properties [Qualitative Concept]
   770   C1292721:properties [Functional Concept]
   737 E C1882134:Property [Conceptual Entity]
   737 E C2347695:Property [Entity]
   715 E C0026597:Motion [Natural Phenomenon or Process]
   715 E C0687704:Motions [Functional Concept]
Processing 00000000.tx.10: The His112 mutants were shown to bind zinc, but with a lower affinity than the wild type enzyme. 

Phrase: "The His112 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "zinc,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "but with a lower affinity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0233535:but [Mental or Behavioral Dysfunction]
   760   C0441994:Lower [Spatial Concept]
   760   C1510827:Affinity [Natural Phenomenon or Process]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]

Phrase: "than the wild type enzyme."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.11: The glutamate mutants displayed an altered cleavage profile for the peptide -endorphin. 

Phrase: "The glutamate mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "an altered cleavage profile for the peptide -endorphin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1979963:Profile [Laboratory Procedure]
   744   C2003903:Profile [Functional Concept]
Processing 00000000.tx.12: Wild type IDE cleaved -endorphin at Leu17-Phe18 and Phe18-Lys19, whereas the glutamate mutants cleaved at these sites, but in addition at Lys19-Asn20 and at Met5-Thr6. 

Phrase: "Wild type IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "cleaved -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: "endorphin at Leu17-Phe18"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0014242:Endorphin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   770   C0205752:endorphin [Biologically Active Substance]

Phrase: "and"

Phrase: "Phe18-Lys19,"

Phrase: "whereas"

Phrase: "the glutamate mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "cleaved at these sites,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205145:Sites [Spatial Concept]
   770   C0205242:Cleaved [Spatial Concept]
   770   C0333853:Cleaved [Cell]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "but in addition"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0233535:but [Mental or Behavioral Dysfunction]
   790   C1883712:Addition [Functional Concept]
   718 E C1524062:Additional [Functional Concept]

Phrase: "at Lys19-Asn20"

Phrase: "and at Met5-Thr6."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]
Processing 00000000.tx.13: Thus, active site mutations of IDE are suggested to not only reduce catalytic activity but also cause local conformational changes that affect the allosteric properties of the enzyme.  

Phrase: "Thus,"

Phrase: "active site mutations of IDE"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0205681:Active Site [Functional Concept]
   774   C2945843:Site of [Qualitative Concept]
   748   C0026882:Mutations [Genetic Function]
   748   C0205145:Site [Spatial Concept]
   748   C0205177:Active [Functional Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "reduce"

Phrase: "catalytic activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0243102:catalytic activity [Molecular Function]
  1000   C1264638:Catalytic activity [Functional Concept]
  1000   C1547012:*Catalytic Activity [Quantitative Concept]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "but"

Phrase: "also"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "local conformational changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C0301641:Conformational change [Molecular Function]
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   793 E C1705241:Change [Quantitative Concept]

Phrase: "that"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the allosteric properties of the enzyme."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0871161:properties [Qualitative Concept]
   753   C1292721:properties [Functional Concept]
   719 E C1882134:Property [Conceptual Entity]
   719 E C2347695:Property [Entity]
Processing 00000000.tx.14: INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  It is generally accepted that the accumulation of amyloid -peptides (A),1 particularly amyloid -peptide 142, plays a central role in the pathogenesis of Alzheimer disease (AD). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "It"

Phrase: "is"

Phrase: "generally"

Phrase: "accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "that"

Phrase: "the accumulation of amyloid -peptides"

Phrase: "(A),1 particularly amyloid -peptide 142,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   799   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a central role in the pathogenesis of Alzheimer disease (AD)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.15: The mechanisms leading to the accumulation of A in late onset AD is currently unknown but could be a result of either overproduction of the peptide or decreased clearance. 

Phrase: "The mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "leading to the accumulation of A in late onset AD"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   797   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   770   C0814122:late disease onset [Finding]
   756   C0002395:Alzheimer's Disease [Disease or Syndrome]
   756   C1521724:Alzheimer's Disease [Pathologic Function]
   754   C0277793:disease onset [Temporal Concept]
   738   C0012634:Disease [Disease or Syndrome]
   738   C0205087:Late [Temporal Concept]
   738   C0332152:Leading [Temporal Concept]
   738   C0332162:Onset [Qualitative Concept]
   738   C1522538:Leading [Functional Concept]
   704 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   704 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   704 E C2348269:Lead [Element, Ion, or Isotope]
   704 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "currently unknown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439673:Unknown [Qualitative Concept]

Phrase: "but"

Phrase: "could"

Phrase: "be"

Phrase: "a result of either overproduction of the peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]

Phrase: "or"

Phrase: "decreased clearance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C2825073:Clearance [Natural Phenomenon or Process]
Processing 00000000.tx.16: In the case of autosomal dominant AD, it is clear that the early onset of the disease is linked to increased A production and results from mutations in one of several genes: APP, PS1 (presenilin 1), or PS2 (presenilin 2) (14). 

Phrase: "In the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of autosomal dominant AD,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "it"

Phrase: "is"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that"

Phrase: "the early onset of the disease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C0814120:early disease onset [Disease or Syndrome]
   790   C1833334:Early-onset [Finding]
   783   C0277793:disease onset [Temporal Concept]
   783   C0679245:early disease [Temporal Concept]
   753   C0332162:Onset [Qualitative Concept]
   753   C1279919:Early [Temporal Concept]

Phrase: "is"

Phrase: "linked to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1517892:Link [Intellectual Product]
   799   C1704666:Link [Intellectual Product]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "results from mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0026882:Mutations [Genetic Function]
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "of several genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: ":"

Phrase: "APP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538722:APP [Laboratory Procedure]

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "(presenilin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "PS2"

Phrase: "(presenilin 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")"

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.17: However, there is only a scattering of evidence that late onset AD is attributable to an overproduction of A (5). 

Phrase: "However,"

Phrase: "there"

Phrase: "is"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a scattering of evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439742:Scattering [Spatial Concept]

Phrase: "that late onset AD"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "attributable to an overproduction of A (5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0596130:Attributable [Mental Process]

Phrase: ")."
Processing 00000000.tx.18: There are recent reports (68) that the -secretase involved in amyloid -peptide synthesis is increased in sporadic AD patients. 

Phrase: "There"

Phrase: "are"

Phrase: "recent reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "(68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")"

Phrase: "that"

Phrase: "the -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "involved in amyloid -peptide synthesis"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   806   C1327133:peptide synthesis [Molecular Function]
   806   C1518961:Peptide Synthesis [Research Activity]
   806   C2945683:Peptide synthesis [Molecular Function]
   762 E C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0220781:synthesis [Biologic Function]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1314939:Involved [Functional Concept]
   760   C1883254:Synthesis [Activity]

Phrase: "is"

Phrase: "increased in sporadic AD patients."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0205217:Increased [Quantitative Concept]
   753   C0205422:Sporadic [Temporal Concept]
   753   C0442805:Increased [Functional Concept]
   737   C0277564:Acquired disease [Disease or Syndrome]
Processing 00000000.tx.19: Whether this increase is a cause of or a consequence of AD and whether this increase in activity will be seen in larger patient populations remains to be established. 

Phrase: "Whether"

Phrase: "this increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "is"

Phrase: "a cause of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0015127:cause [Functional Concept]
   790   C1524003:Cause [Conceptual Entity]

Phrase: "or"

Phrase: "a consequence of AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "and"

Phrase: "whether"

Phrase: "this increase in activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "will"

Phrase: "be"

Phrase: "seen in larger patient populations"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0030705:*^patient [Patient or Disabled Group]
   760   C0032659:Population [Quantitative Concept]
   760   C0205397:Seen [Qualitative Concept]
   760   C0443228:larger [Quantitative Concept]
   760   C0549177:Larger [Quantitative Concept]
   760   C1257890:Population [Population Group]
   760   C1704243:Larger [Quantitative Concept]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "established."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]
Processing 00000000.tx.20: Clearance of A is currently receiving considerable attention as a key regulatory mechanism of brain A levels. 

Phrase: "Clearance of A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0449297:Clearance [Qualitative Concept]
   790   C1382187:Clearance [Clinical Attribute]
   790   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "currently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521116:Currently [Temporal Concept]

Phrase: "receiving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514756:Receive [Qualitative Concept]

Phrase: "considerable attention as a key regulatory mechanism of brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0004268:Attention [Mental Process]

Phrase: "A levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.21: There appear to be two paths for A clearance in the brain. 

Phrase: "There"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "two paths for A clearance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0919386:PATH [Laboratory Procedure]
   726   C1705483:Path [Intellectual Product]

Phrase: "in the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.22: One pathway involves the equilibration of A between the central nervous system and plasma mediated through cerebral spinal fluid (911). 

Phrase: "One pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "involves"

Phrase: "the equilibration of A between the central nervous system"

Phrase: "and"

Phrase: "plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "mediated through cerebral spinal fluid"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0007806:Cerebral Spinal Fluid [Body Substance]
           Spinal fluid
   760   C0005889:FLUID [Body Substance]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0302908:fluid [Substance]
   760   C0444611:Fluid [Qualitative Concept]
   760   C0521329:Spinal [Spatial Concept]
   760   C1704353:Fluid [Substance]

Phrase: "(911"

Phrase: ")."
Processing 00000000.tx.23: The other pathway involves clearance of A through proteolysis (1215). 

Phrase: "The"

Phrase: "other pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]

Phrase: "involves"

Phrase: "clearance of A through proteolysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0449297:Clearance [Qualitative Concept]
   760   C1382187:Clearance [Clinical Attribute]
   760   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "(1215"

Phrase: ")."
Processing 00000000.tx.24: There are a number of peptidases that have been implicated in A clearance. 

Phrase: "There"

Phrase: "are"

Phrase: "a number of peptidases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "that"

Phrase: "have"

Phrase: "been"

Phrase: "implicated in A clearance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449297:Clearance [Qualitative Concept]
   770   C1382187:Clearance [Clinical Attribute]
   770   C2825073:Clearance [Natural Phenomenon or Process]
Processing 00000000.tx.25: Those that have received the most attention and are supported by in vivo studies in peptidase-deficient mice include neprilysin (16, 17), insulysin (IDE) (18, 19), and endothelin-converting enzyme (20, 21). 

Phrase: "Those"

Phrase: "that"

Phrase: "have"

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "the most attention"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004268:Attention [Mental Process]

Phrase: "and"

Phrase: "are"

Phrase: "supported by in vivo studies"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   845   C0681829:in vivo study [Research Activity]
           studies vivo
   806   C1515655:In Vivo [Spatial Concept]
           vivo
   760   C0947630:studies [Laboratory Procedure]
   760   C1521721:Supported [Conceptual Entity]
   726 E C0183683:Support [Medical Device]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "in peptidase-deficient mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "(16,"

Phrase: "17"

Phrase: ")"

Phrase: ","

Phrase: "insulysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULYSIN [Gene or Genome]

Phrase: "(IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "(18,"

Phrase: "19"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "endothelin-converting enzyme"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C2745878:endothelin-converting enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0079284:Endothelin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "(20,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.26: Genetic studies have further suggested a linkage between late onset AD and IDE. 

Phrase: "Genetic studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C2827447:Genetic Study [Research Activity]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a linkage between late onset AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0023745:linkage [Molecular Function]

Phrase: "and"

Phrase: "IDE."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.27: A linkage of a region of chromosome 10q to late onset Alzheimer disease has been reported by several groups (2225). 

Phrase: "A linkage of a region of chromosome 10q"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0023745:linkage [Molecular Function]

Phrase: "to late onset Alzheimer disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "reported by several groups"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C1709908:Reported By [Group]
   770   C0441833:Group [Idea or Concept]
   770   C0684224:Reported [Intellectual Product]
   770   C0687744:group [Population Group]
   770   C0700287:Reported [Health Care Activity]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "(2225"

Phrase: ")."
Processing 00000000.tx.28: This region of the chromosome is within 195 kilobases of the IDE gene. 

Phrase: "This region of the chromosome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C1953345:Region of chromosome [Cell]
           Chromosome region
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]

Phrase: "is within 195 kilobases of the IDE gene."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   782   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   782   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C1333402:Enzyme Gene [Gene or Genome]
   757   C0314622:Is gene [Gene or Genome]
   757   C1337112:Insulin Gene [Gene or Genome]
   739   C0014442:Enzyme [Enzyme,Organic Chemical]
   739   C0017337:Gene [Gene or Genome]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
   706   C0582519:kilobase [Quantitative Concept]
Processing 00000000.tx.29: However, to date this analysis has not been refined to the point where the linkage to IDE can be unequivocally established. 

Phrase: "However,"

Phrase: "to date"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "this analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "refined to the point where"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1552961:Point [Quantitative Concept]
   760   C2347617:point [Quantitative Concept]

Phrase: "the linkage to IDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0023745:linkage [Molecular Function]

Phrase: "can"

Phrase: "be"

Phrase: "unequivocally"

Phrase: "established."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]
Processing 00000000.tx.30: IDE (EC 3.4.24.56 [EC] ) is an 110-kDa zinc metallopeptidase containing an inverted form of the signature active site sequence (HXXEH) and is thus known as an inverzincin. 

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(EC 3.4.24.56"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "[EC] )"

Phrase: "is"

Phrase: "an 110-kDa zinc metallopeptidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0025543:Metallopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "an inverted form of the signature active site sequence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0348078:Form [Qualitative Concept]
   742   C0376315:Form [Manufactured Object]
   742   C1522492:Form [Functional Concept]

Phrase: "(HXXEH"

Phrase: ")"

Phrase: "and"

Phrase: "is"

Phrase: "thus"

Phrase: "known as an inverzincin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205309:Known [Qualitative Concept]
Processing 00000000.tx.31: The enzyme is primarily cytosolic, although a fraction of the enzyme is peroxisomal due to the presence of a C-terminal peroxisomal targeting sequence (26). 

Phrase: "The enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "is"

Phrase: "primarily cytosolic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1383501:Cytosolic [Cell Component]

Phrase: "although"

Phrase: "a fraction of the enzyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1264633:Fraction of [Quantitative Concept]
           Fraction
   760   C1554103:Fraction [Idea or Concept]

Phrase: "is"

Phrase: "peroxisomal due to the presence of a C-terminal peroxisomal targeting sequence"

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.32: IDE has also been reported as being located on the cell surface and secreted (2729). 

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "as"

Phrase: "being"

Phrase: "located on the cell surface"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "(2729"

Phrase: ")."
Processing 00000000.tx.33: Farris et al. 

Phrase: "Farris et al."
Processing 00000000.tx.34: (30) have shown that naturally occurring IDE missense mutations in the rat result in decreased insulin and A degradation. 

Phrase: "(30"

Phrase: ")"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that naturally"

Phrase: "occurring"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1709305:Occur [Activity]
   966   C2745955:OCCUR [Temporal Concept]

Phrase: "IDE missense mutations in the rat result"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   764   C0599155:Mutations, Missense [Genetic Function]
   742   C0026882:Mutations [Genetic Function]
   708 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in decreased insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "A degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]
Processing 00000000.tx.35: Primary neuronal cultures derived from these rats secrete increased levels of A peptides; 

Phrase: "Primary neuronal cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0010453:Cultures [Idea or Concept]
   793 E C0220814:culture [Functional Concept]
   793 E C0430400:Culture [Laboratory Procedure]
   793 E C2242979:Culture [Laboratory Procedure]

Phrase: "derived from these rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "secrete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:secrete [Cell Function]

Phrase: "increased levels of A peptides"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.36: however, the steady-state level of brain A in these animals is unaffected, suggesting compensatory mechanisms. 

Phrase: "however,"

Phrase: "the steady-state level of brain A"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0678587:steady state [Natural Phenomenon or Process]
   778   C0683927:state level [Spatial Concept]
   748   C0205361:Steady [Qualitative Concept]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1301808:State [Geographic Area]
   748   C1442792:State [Functional Concept]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]
   748   C3148680:State [Geographic Area]

Phrase: "in these animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "is"

Phrase: "unaffected,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986417:Unaffected [Conceptual Entity]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "compensatory mechanisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.37: The specificity of IDE is complex. 

Phrase: "The specificity of IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0678612:enzyme specificity [Natural Phenomenon or Process]
   753   C0037791:Specificity [Quantitative Concept]
   753   C1511884:Specificity [Quantitative Concept]

Phrase: "is"

Phrase: "complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.38: The enzyme cleaves a variety of peptides primarily, but not exclusively, at basic or bulky hydrophobic residues (31, 32). 

Phrase: "The enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "cleaves"

Phrase: "a variety of peptides primarily,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]

Phrase: "but"

Phrase: "not exclusively,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "at basic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527178:Basic [Functional Concept]
   928 E C0920750:basicity [Quantitative Concept]

Phrase: "or"

Phrase: "bulky hydrophobic residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.39: Kurochkin (33) has suggested that IDE cleaves peptides that have a propensity to form -pleated sheet structures. 

Phrase: "Kurochkin"

Phrase: "(33"

Phrase: ")"

Phrase: "has"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "cleaves"

Phrase: "peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "that"

Phrase: "have"

Phrase: "a propensity to"

Phrase: "form -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "pleated sheet structures."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:structures [Spatial Concept]
Processing 00000000.tx.40: Cleavage of A by IDE results in the loss of the neurotoxic effects of the peptide and prevents the deposition of A onto a synthetic amyloid deposit (34). 

Phrase: "Cleavage of A by IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "results in the loss of the neurotoxic effects of the peptide"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   739   C0235032:Neurotoxic effect [Injury or Poisoning]
   738   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   738   C1274040:Result [Functional Concept]
   738   C1280500:effects [Qualitative Concept]
   738   C1517945:Loss [Quantitative Concept]
   738   C1546471:Result [Idea or Concept]
   738   C2825142:Result [Finding]
   704 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "the deposition of A onto a synthetic amyloid deposit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0011560:Amyloid deposition [Pathologic Function]
   762   C1705760:Amyloid Deposition [Finding]
   742   C0333562:Deposition [Functional Concept]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.41: We have recently shown that IDE exhibits allosteric properties being activated by peptide substrates. 

Phrase: "We"

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "allosteric properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]

Phrase: "being"

Phrase: "activated by peptide substrates."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]
   737   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.42: Interestingly, peptides activated IDE toward A peptide cleavage but not toward insulin cleavage (35). 

Phrase: "Interestingly,"

Phrase: "peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "IDE toward A peptide cleavage"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "but"

Phrase: "not toward insulin cleavage"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0010813:cleavage [Cell Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]
   770   C1518422:Not [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.43: We further established that IDE exists as a mixture of monomers, dimers, and tetramers. 

Phrase: "We further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "exists as a mixture of monomers,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439962:Mixture [Substance]
   753   C0596973:monomers [Chemical Viewed Structurally]
   753   C2987476:Exist [Conceptual Entity]

Phrase: "dimers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596448:dimers [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "tetramers."
Processing 00000000.tx.44: During the course of our studies on the allosteric properties of IDE, we generated a number of active site mutants as control enzymes. 

Phrase: "During the course"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750729:Course [Temporal Concept]

Phrase: "of our studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "on the allosteric properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]

Phrase: "of IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "we"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "a number of active site mutants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "as control enzymes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]
Processing 00000000.tx.45: We noted that although the activity of these mutants was significantly reduced, the residual catalytic properties were altered. 

Phrase: "We"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "although"

Phrase: "the activity of these mutants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "significantly"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: ","

Phrase: "the residual catalytic properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0871161:properties [Qualitative Concept]
   827   C1292721:properties [Functional Concept]
   793 E C1882134:Property [Conceptual Entity]
   793 E C2347695:Property [Entity]

Phrase: "were"

Phrase: "altered."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]
Processing 00000000.tx.46: We report here the results of these studies.  

Phrase: "We"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "here"

Phrase: "the results of these studies."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683954:results studies [Finding]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]
Processing 00000000.tx.47: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Synthesis of the fluorogenic peptide substrate Abz-GGFLRKHGQEDDnp was as previously described (36). 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Synthesis of the fluorogenic peptide substrate Abz-GGFLRKHGQEDDnp"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   767   C1327133:peptide synthesis [Molecular Function]
   767   C1518961:Peptide Synthesis [Research Activity]
   767   C2945683:Peptide synthesis [Molecular Function]
   744   C0220781:synthesis [Biologic Function]
   744   C1883254:Synthesis [Activity]
   731 E C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.48: Dynorphin A-9, dynorphin A-10, dynorphin A-17, dynorphin B-9, and insulin were obtained from Bachem. 

Phrase: "Dynorphin A-9,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0086191:Dynorphin A [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0013355:Dynorphin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418447:dynorphin [Gene or Genome]

Phrase: "dynorphin A-10,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0086191:Dynorphin A [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0013355:Dynorphin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418447:dynorphin [Gene or Genome]

Phrase: "dynorphin A-17,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0086191:Dynorphin A [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0013355:Dynorphin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418447:dynorphin [Gene or Genome]

Phrase: "dynorphin B-9,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0073381:Dynorphin B [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   827   C0013355:Dynorphin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418447:dynorphin [Gene or Genome]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "obtained from Bachem."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.49: Amyloid peptide 140 was a product of California Research Peptide Inc. 

Phrase: "Amyloid peptide 140"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "a product of California"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1514468:product [Entity]
   770   C1704444:Product [Quantitative Concept]

Phrase: "Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "Peptide Inc."
Processing 00000000.tx.50: -endorphin was obtained from Multiple Peptide Systems through the National Institute on Drug Abuse Research Tools program. 

Phrase: "-endorphin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014242:Endorphin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C0205752:endorphin [Biologically Active Substance]

Phrase: "was"

Phrase: "obtained from Multiple Peptide Systems"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0439064:Multiple [Quantitative Concept]
   760   C1301820:Obtained [Functional Concept]
   726   C0449913:System [Functional Concept]
   726   C1553451:System [Manufactured Object]
   726   C1704459:System [Medical Device]
   726 E C1706701:Obtain [Activity]

Phrase: "through the National Institute on Drug Abuse Research Tools"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0336791:Tool [Manufactured Object]
   762   C2827396:Tool [Manufactured Object]
   747   C1513899:National Institute on Drug Abuse [Health Care Related Organization]

Phrase: "program."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1709697:Program [Conceptual Entity]
  1000   C2728259:Program [Pharmacologic Substance]
  1000   C3484370:Program [Functional Concept]
Processing 00000000.tx.51: All other reagents were obtained as the best grade available commercially. 

Phrase: "All"

Phrase: "other reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "obtained as the best"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1301820:Obtained [Functional Concept]
   770   C1522427:Best [Qualitative Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "grade"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441800:Grade [Classification]
  1000   C0919553:Grade [Classification]
  1000   C3244287:grade [Finding]

Phrase: "available commercially."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0470187:Available [Functional Concept]
Processing 00000000.tx.52: Activity AssaysIDE activity was routinely measured with the fluorogenic peptide Abz-GGFLRKHGQ-EDDnp. 

Phrase: "Activity AssaysIDE activity"

Phrase: "was"

Phrase: "routinely"

Phrase: "measured with the fluorogenic peptide Abz-GGFLRKHGQ-EDDnp."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   800   C1566515:abz-GGFLRKHGQ-EDDnp [Amino Acid, Peptide, or Protein]
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   744   C0444706:Measured [Qualitative Concept]
   744   C3541902:MEASURED [Diagnostic Procedure]
   711 E C0079809:Measure [Quantitative Concept]
   711 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.53: The increase in fluorescence that occurred upon cleavage of the peptide between residues R and K (36) was followed on a SpectraMax Gemini XS fluorescence plate reader using an excitation wavelength of 318 nm and an emission wavelength of 419 nm. 

Phrase: "The increase in fluorescence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "that"

Phrase: "occurred upon cleavage of the peptide"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0010813:cleavage [Cell Function]
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]
   753   C1709305:Occurred [Activity]
   719 E C2745955:OCCUR [Temporal Concept]

Phrase: "between residues R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "K (36"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "followed on a SpectraMax Gemini XS fluorescence plate reader"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   742   C0005971:Plate [Medical Device]
   742   C0016315:Fluorescence [Natural Phenomenon or Process]
   742   C0332283:followed [Temporal Concept]
   742   C1139930:plate [Medical Device]
   742   C1421550:XS [Gene or Genome]
   742   C1514743:Reader [Professional or Occupational Group]
   742   C1706461:Reader [Manufactured Object]
   742   C3537155:Plate [Manufactured Object]
   708 E C1719822:Follow [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an excitation wavelength of 318 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449819:Wavelength [Quantitative Concept]

Phrase: "and"

Phrase: "an emission wavelength of 419 nm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449819:Wavelength [Quantitative Concept]
Processing 00000000.tx.54: The IDE-dependent hydrolysis of insulin, -endorphin, amyloid -peptide 140, and dynorphin peptides was followed by reverse phase HPLC using a C4 column and a linear gradient from 0.1% trifluoroacetic acid in 95% water, 5% acetonitrile to 0.1% trifluoroacetic acid in 50% water, 50% acetonitrile. 

Phrase: "The IDE-dependent hydrolysis of insulin, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "endorphin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014242:Endorphin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C0205752:endorphin [Biologically Active Substance]

Phrase: "amyloid -peptide 140,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "dynorphin peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "followed by reverse phase HPLC"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C1555029:Reverse [Idea or Concept]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a C4 column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: "and"

Phrase: "a linear gradient from 0.1% trifluoroacetic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439182:% gradient [Quantitative Concept]
   744   C0812409:Gradient [Quantitative Concept]

Phrase: "in 95% water,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0599638:WATER [Substance]
   861   C1550678:Water [Inorganic Chemical]
   789 E C0443350:Watery [Qualitative Concept]

Phrase: "5% acetonitrile to 0.1% trifluoroacetic acid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0050456:acetonitrile [Organic Chemical]

Phrase: "in 50% water,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0599638:WATER [Substance]
   861   C1550678:Water [Inorganic Chemical]
   789 E C0443350:Watery [Qualitative Concept]

Phrase: "50% acetonitrile."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050456:acetonitrile [Organic Chemical]
Processing 00000000.tx.55: Peptides were followed by their absorbance at 214 nm and quantified from their peak area. 

Phrase: "Peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "followed by their absorbance"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C1268822:Absorbance [Clinical Attribute]
   770   C2825050:Absorbance [Phenomenon or Process]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "at 214 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "quantified from their peak area."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017446:Area [Geographic Area]
   760   C0205146:Area [Spatial Concept]
   760   C0444505:Peak [Quantitative Concept]
   726   C1709793:Quantify [Quantitative Concept]
Processing 00000000.tx.56: Preparation and Purification of IDE MutantsThe various His112 and Glu111 rat IDE mutants were prepared in pFast Bac HTb using the site-directed mutagenesis kit from Stratagene. 

Phrase: "Preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "and"

Phrase: "Purification of IDE MutantsThe various His112"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0243114:purification [Functional Concept]
   744   C1998793:Purification [Functional Concept]

Phrase: "and"

Phrase: "Glu111 rat IDE mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "prepared in pFast Bac HTb"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0048733:HTB [Organic Chemical]
   726   C1521827:Prepare [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the site-directed mutagenesis kit from Stratagene."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0812225:KIT [Medical Device]
   748   C1150635:KIT [Molecular Function]
   748   C1705212:Kit [Medical Device]
   748   C1705213:KIT [Medical Device]
   748   C3273202:Kit [Manufactured Object]
Processing 00000000.tx.57: (It should be noted that a methionine located 42 residues downstream of methionine 1 of the IDE cDNA appears to represent the major translational start site (37). Thus, His112 would actually be His70, and Glu111 would be Glu69. We have however retained the original numbering system to avoid confusion with earlier publications). 

Phrase: "("

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "a methionine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "located"

Phrase: "42 residues downstream of methionine 1 of the IDE cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   703   C1709915:Residue [Conceptual Entity]
   703   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the major translational start site"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0205145:Site [Spatial Concept]
   812   C0439659:Start [Temporal Concept]
   812   C1515974:Site [Body Location or Region]
   812   C1519614:Translational [Genetic Function]
   812   C2825164:Site [Spatial Concept]
   741 E C0040712:Translation [Intellectual Product]
   741 E C0597295:translation [Molecular Function]

Phrase: "(37"

Phrase: "). Thus,"

Phrase: "His112"

Phrase: "would"

Phrase: "actually"

Phrase: "be"

Phrase: "His70,"

Phrase: "and"

Phrase: "Glu111"

Phrase: "would"

Phrase: "be"

Phrase: "Glu69."

Phrase: "We"

Phrase: "have"

Phrase: "however"

Phrase: "retained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retained [Functional Concept]

Phrase: "the original numbering system to"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0870982:numbering system [Intellectual Product]
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "avoid"

Phrase: "confusion with earlier publications"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0009676:Confusion [Mental or Behavioral Dysfunction]
   770   C1963086:Confusion [Finding]

Phrase: ")."
Processing 00000000.tx.58: The oligonucleotides used for mutagenesis, with the base changes from the wild type sequence underlined, are listed in Table I. 

Phrase: "The oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "used for mutagenesis,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0079866:Mutagenesis [Molecular Function]
   790   C1273517:used [Finding]
   790   C3146302:Mutagenesis [Laboratory Procedure]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "with the base changes"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0002055:base [Inorganic Chemical]
   861   C0178499:Base [Chemical Viewed Functionally]
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   861   C1880279:Base [Biomedical or Dental Material]
   827 E C1705241:Change [Quantitative Concept]
   789 E C0205112:Basal [Spatial Concept]
   777 E C0016617:Foundation [Organization]
   777 E C1626935:Bases [Quantitative Concept]

Phrase: "from the wild type sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "underlined"

Phrase: ","

Phrase: "are"

Phrase: "listed in Table I."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0021966:I- [Inorganic Chemical]
   770   C0039224:Table [Manufactured Object]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C0745732:List [Conceptual Entity]
   737   C3272378:LIST [Intellectual Product]
Processing 00000000.tx.59: View this table: [in this window] [in a new window]  TABLE I Oligonucleotides used  Based on the secondary structure predicting programs PHD (38) and PHDsec (39), IDE is predicted to have a helical region from residues 107 to 116, which encompasses the mutated residues. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE I Oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Based on the secondary structure predicting"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0162807:Secondary Structure [Spatial Concept]
   753   C0027627:secondary [Neoplastic Process]
   753   C0175668:Secondary [Temporal Concept]
   753   C0205436:Secondary [Quantitative Concept]
   753   C0678594:Structure [Spatial Concept]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "programs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0376691:Programs [Intellectual Product]
  1000   C1709697:Program [Conceptual Entity]
  1000   C2728259:Program [Pharmacologic Substance]
  1000   C3484370:Program [Functional Concept]

Phrase: "PHD (38"

Phrase: ")"

Phrase: "and"

Phrase: "PHDsec"

Phrase: "(39"

Phrase: ")"

Phrase: ","

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "a helical region from residues 107"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]

Phrase: "to 116,"

Phrase: "which"

Phrase: "encompasses"

Phrase: "the mutated residues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.60: None of the mutations were predicted to affect the ability of this region to form a helix. 

Phrase: "None of the mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0026882:Mutations [Genetic Function]
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the ability of this region to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a helix."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018882:Helix [Eukaryote]
  1000   C0229304:Helix [Body Part, Organ, or Organ Component]
  1000   C1704821:Helix [Spatial Concept]
  1000   C1705682:Helix [Anatomical Structure]
Processing 00000000.tx.61: Recombinant IDE and the various mutants were expressed in Sf-9 cells as a fusion protein containing an N-terminal hexahistidine affinity tag followed by a linker containing a tobacco etch virus protease cleavage site (35). 

Phrase: "Recombinant IDE"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   861   C1533581:Recombinant Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
           Insulin
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "the various mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "expressed in Sf-9 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "as a fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "an N-terminal hexahistidine affinity tag"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0037293:Tag [Neoplastic Process]
   804   C0181496:Tag [Manufactured Object]
   804   C1710492:TAG [Gene or Genome]

Phrase: "followed by a linker"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0332283:Followed by [Temporal Concept]
           followed
   737 E C1719822:Follow [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a tobacco etch virus protease cleavage site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0205145:Site [Spatial Concept]
   799   C1515974:Site [Body Location or Region]
   799   C2825164:Site [Spatial Concept]
   734   C0389661:tobacco etch virus protease [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.62: Wild type and IDE mutants were purified on a His-Select HC nickel affinity gel column (Sigma). 

Phrase: "Wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "IDE mutants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0596988:mutants [Cell or Molecular Dysfunction]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "were"

Phrase: "purified on a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1998793:Purified [Functional Concept]

Phrase: "His-"

Phrase: "Select"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Select [Activity]

Phrase: "HC nickel affinity gel column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1185738:Column [Body Part, Organ, or Organ Component]
   804   C1706132:Column [Idea or Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.63: In most experiments, the enzyme was used as the His6-IDE; 

Phrase: "In most experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "used as the His6-IDE"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   814   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   774   C0240016:Insulin used [Finding]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1273517:used [Finding]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.64: however, to verify the lack of an effect of the N-terminal hexahistidine and linker, tobacco etch virus protease was used to remove this region as previously described (35). 

Phrase: "however,"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "the lack of an effect of the N-terminal hexahistidine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0332268:lack [Qualitative Concept]

Phrase: "and"

Phrase: "linker,"

Phrase: "tobacco etch virus protease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0389661:tobacco etch virus protease [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C1947941:Protease [Enzyme]
   756   C1000323:Tobacco etch virus [Virus]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "this region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.65: Sedimentation Equilibrium AnalysisAnalytical ultracentrifugation was performed at 4.0  0.1 C in a Beckman XL-A centrifuge using an AN 60 Ti rotor. 

Phrase: "Sedimentation Equilibrium AnalysisAnalytical ultracentrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0041609:Ultracentrifugation [Laboratory Procedure]

Phrase: "was"

Phrase: "performed at 4.0  0.1 C in"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0884358:Performed [Functional Concept]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a Beckman XL-"

Phrase: "A centrifuge"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0179834:centrifuge [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an AN 60 Ti rotor."
Processing 00000000.tx.66: Scans were obtained at 280 nm with a step size of 0.001 cm. 

Phrase: "Scans"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034606:Scan [Diagnostic Procedure]
  1000   C0441633:Scan [Diagnostic Procedure]
  1000   C2826292:SCAN [Finding]

Phrase: "were"

Phrase: "obtained at 280 nm"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0312860:NM [Cell Function]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "with a step size"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0808077:Stepsize [Organism Attribute]
   861   C0456389:size [Spatial Concept]
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: "of 0.001 cm."
Processing 00000000.tx.67: The approach to equilibrium was considered to be complete when scans made 6 h apart were indistinguishable. 

Phrase: "The approach to equilibrium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449445:Approach [Spatial Concept]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "complete"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205197:Complete [Qualitative Concept]
  1000   C0725685:COMPLEAT [Food]
   928 E C0439812:Completeness [Qualitative Concept]

Phrase: "when"

Phrase: "scans"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034606:Scan [Diagnostic Procedure]
  1000   C0441633:Scan [Diagnostic Procedure]
  1000   C2826292:SCAN [Finding]

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "6 h apart"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "were"

Phrase: "indistinguishable."
Processing 00000000.tx.68: Typically, equilibration times equal to or greater than 20 h met this criterion. 

Phrase: "Typically,"

Phrase: "equilibration times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "equal to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205163:Equal To [Qualitative Concept]
           Equal
   833   C1549782:Equal [Idea or Concept]

Phrase: "or"

Phrase: "greater than 20 h"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0439093:Greater Than [Quantitative Concept]
   770   C0443228:greater [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]

Phrase: "met"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Meet [Idea or Concept]

Phrase: "this criterion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243161:Criterion [Intellectual Product]
Processing 00000000.tx.69: Five scans were averaged for each sample at each rotor speed. 

Phrase: "Five scans"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034606:Scan [Diagnostic Procedure]
   861   C0441633:Scan [Diagnostic Procedure]
   861   C2826292:SCAN [Finding]

Phrase: "were"

Phrase: "averaged for each sample"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0370003:Sample [Substance]
   770   C2347026:Sample [Conceptual Entity]
   737   C1510992:Average [Quantitative Concept]
   737   C2825518:AVERAGE [Quantitative Concept]

Phrase: "at each rotor speed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678536:Speed [Quantitative Concept]
Processing 00000000.tx.70: Previous results (3) indicated that IDE self-associates in a monomer-dimer-tetramer pattern. 

Phrase: "Previous results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that IDE self-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0036588:Self [Idea or Concept]
   812   C1551994:self [Intellectual Product]
   812   C3244295:Self [Intellectual Product]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "associates in a monomer-dimer-tetramer pattern."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039686:Tetramere [Eukaryote]
   748   C0449774:Pattern [Spatial Concept]
   748   C0596448:dimer [Chemical Viewed Structurally]
   748   C0596973:Monomer [Chemical Viewed Structurally]
   748   C0750490:Associate [Idea or Concept]
   748   C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.71: Sedimentation equilibrium data were therefore analyzed according to Equation 1, (Eq.1) where A(r) is the absorbance at radial position r, and m,0, d,0, and t,0 are the absorbances of monomer, dimer, and tetramer, respectively, at the reference radius (ro). 

Phrase: "Sedimentation equilibrium data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C0597429:sedimentation equilibrium [Natural Phenomenon or Process]

Phrase: "were"

Phrase: "therefore"

Phrase: "analyzed according to Equation 1, (Eq.1)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0552449:Equation [Conceptual Entity]
   760   C0680240:according [Social Behavior]
   760   C0936012:Analyzed [Research Activity]

Phrase: "where A(r)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "is"

Phrase: "the absorbance at radial position r,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1268822:Absorbance [Clinical Attribute]
   753   C2825050:Absorbance [Phenomenon or Process]

Phrase: "and"

Phrase: "m,"

Phrase: "0,"

Phrase: "d,"

Phrase: "0,"

Phrase: "and"

Phrase: "t,0"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "are"

Phrase: "the absorbances of monomer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1268822:Absorbance [Clinical Attribute]
   737   C2825050:Absorbance [Phenomenon or Process]

Phrase: "dimer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596448:dimer [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "tetramer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039686:Tetramere [Eukaryote]

Phrase: "respectively,"

Phrase: "at the reference radius"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034627:Radius [Body Part, Organ, or Organ Component]
   861   C1279083:Radius [Body Part, Organ, or Organ Component]
   861   C1306504:Radius [Quantitative Concept]

Phrase: "(ro"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035826:RO [Geographic Area]
  1000   C1413096:RO [Gene or Genome]
  1000   C2987048:RO [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.72: The parameter m is the reduced molecular weight of the monomer (m = Mm(1 )2/(2RT)); 

Phrase: "The parameter m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "is"

Phrase: "the reduced molecular weight of the monomer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0026385:Molecular Weight [Quantitative Concept]
   748   C0005910:weight [Organism Attribute]
   748   C0043100:Weight [Quantitative Concept]
   748   C1305866:weight [Diagnostic Procedure]
   748   C1521991:Molecular [Qualitative Concept]
   748   C1705104:Weight [Idea or Concept]

Phrase: "("

Phrase: "m ="

Phrase: "Mm(1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418486:MM-1 [Gene or Genome]

Phrase: ")"

Phrase: "2/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(2RT"

Phrase: ")"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.73: Mm is the monomer molecular weight; 

Phrase: "Mm"

Phrase: "is"

Phrase: "the monomer molecular weight"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0026385:Molecular Weight [Quantitative Concept]
   827   C0005910:weight [Organism Attribute]
   827   C0043100:Weight [Quantitative Concept]
   827   C1305866:weight [Diagnostic Procedure]
   827   C1521991:Molecular [Qualitative Concept]
   827   C1705104:Weight [Idea or Concept]
   755 E C0567416:Molecule [Substance]

Phrase: ";"
Processing 00000000.tx.74: is partial specific volume; 

Phrase: "is"

Phrase: "partial specific volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0449468:*Volume [Quantitative Concept]
   827   C1690016:% volume [Qualitative Concept]
   827   C1705102:Volume [Intellectual Product]
   827   C2700258:Volume [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.75: is the solvent density, is the rotor angular velocity, R is the gas constant, T is the absolute temperature, and is the base-line offset. 

Phrase: "is"

Phrase: "the solvent density,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0178587:density [Quantitative Concept]
   789 E C0439794:Dense [Qualitative Concept]

Phrase: "is"

Phrase: "the rotor angular velocity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439830:Velocity [Quantitative Concept]
   827   C1547053:*Velocity [Quantitative Concept]

Phrase: "R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "is"

Phrase: "the gas constant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1547014:*Constant [Quantitative Concept]
   861   C1948059:Constant [Qualitative Concept]

Phrase: "T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "is"

Phrase: "the absolute temperature,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C0205344:Absolute [Qualitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "the base-line offset."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1711330:Offset [Quantitative Concept]
   734   C0168634:baseline [Biomedical or Dental Material]
   734   C1442488:Baseline [Quantitative Concept]
Processing 00000000.tx.76: Solvent density was measured using a Mettler density meter. 

Phrase: "Solvent density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0178587:density [Quantitative Concept]
   789 E C0439794:Dense [Qualitative Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Mettler density meter."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0475209:Meter [Quantitative Concept]
   827   C1706378:METER [Manufactured Object]
Processing 00000000.tx.77: The partial specific volume of IDE was calculated from its amino acid composition using the method of Cohn and Edsall (40). 

Phrase: "The partial specific volume of IDE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0449468:*Volume [Quantitative Concept]
   744   C1690016:% volume [Qualitative Concept]
   744   C1705102:Volume [Intellectual Product]
   744   C2700258:Volume [Laboratory Procedure]

Phrase: "was"

Phrase: "calculated from its amino acid composition"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0444686:Calculated [Functional Concept]
   753   C0486616:Composition [Clinical Attribute]
   753   C1441506:Calculated [Activity]
   753   C1443182:Calculated [Laboratory Procedure]
   753   C1555710:composition [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the method of Cohn"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025663:Method [Intellectual Product]
   770   C0449851:Method [Functional Concept]
   770   C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "Edsall"

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.78: Data sets obtained for samples run at three different rotor speeds were fit simultaneously to Equation 1 using the global fitting method first described by Johnson and co-workers (41).  

Phrase: "Data sets"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0150098:data sets [Intellectual Product]
   861   C0036849:Set [Mental Process]
   861   C1442518:Set [Functional Concept]
   861   C1511726:Data [Idea or Concept]
   861   C1705195:Set [Conceptual Entity]
   861   C3245479:data [Medical Device]

Phrase: "obtained for samples"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   841   C1277697:Sample obtained [Finding]
   790   C1301820:Obtained [Functional Concept]
   756   C0370003:Sample [Substance]
   756 E C1706701:Obtain [Activity]
   756   C2347026:Sample [Conceptual Entity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "run at three different rotor speeds"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0035953:run [Daily or Recreational Activity]
   753   C0205449:Three [Quantitative Concept]
   753   C0600140:run [Finding]
   753   C0678536:speeds [Quantitative Concept]
   753   C1704688:Run [Functional Concept]
   753   C1705242:Different [Qualitative Concept]
   753   C2346414:Run [Finding]

Phrase: "were"

Phrase: "fit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036572:Fit [Sign or Symptom]
  1000   C0424576:Fit [Finding]
  1000   C2349186:Fit [Activity]

Phrase: "simultaneously to Equation 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0521115:simultaneously [Temporal Concept]
   770   C0552449:Equation [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the global fitting method first"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025663:Method [Intellectual Product]
   812   C0449851:Method [Functional Concept]
   812   C0871511:METHOD [Intellectual Product]

Phrase: "described by Johnson"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "co-workers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024752:workers [Functional Concept]
   861   C1306056:workers [Occupation or Discipline]
   861   C1527116:Workers [Population Group]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.79: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  IDE is a zinc metallopeptidase of the inverzincin family containing the signature active site sequence H108XXEH. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "a zinc metallopeptidase of the inverzincin family"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0025543:Metallopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the signature active site sequence H108XXEH."
Processing 00000000.tx.80: The two histidines, in conjunction with a downstream glutamate (Glu189) are believed to act as ligands for the active site zinc (37, 42). 

Phrase: "The two histidines,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019602:Histidine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "in conjunction with a downstream glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Glu189"

Phrase: ")"

Phrase: "are"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "act as ligands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0023688:Ligands [Chemical]
   790   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "for the active site zinc"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C2348288:Zinc [Element, Ion, or Isotope]
   734   C0205681:Active Site [Functional Concept]

Phrase: "(37,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.81: As with other zincins, glutamate 111 is believed to be directly involved in catalysis, most probably acting as a general base to facilitate removal of a proton from a water molecule as it attacks the scissile bond. 

Phrase: "As with other zincins,"

Phrase: "glutamate 111"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "involved in catalysis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007382:Catalysis [Natural Phenomenon or Process]
   790   C1314939:Involved [Functional Concept]

Phrase: "most probably"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205393:Most [Quantitative Concept]
   861   C0750492:Probably [Idea or Concept]

Phrase: "acting as a general base to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0002055:base [Inorganic Chemical]
   753   C0178499:Base [Chemical Viewed Functionally]
   753   C0205246:General [Spatial Concept]
   753   C1553889:General [Idea or Concept]
   753   C1880279:Base [Biomedical or Dental Material]
   719   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "facilitate"

Phrase: "removal of a proton"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015252:Removal [Therapeutic or Preventive Procedure]
   770   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "from a water molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:Molecule [Substance]
   789 E C1521991:Molecular [Qualitative Concept]

Phrase: "as"

Phrase: "it"

Phrase: "attacks"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0277793:Attack, NOS [Temporal Concept]
  1000   C1261512:attack [Social Behavior]
  1000   C1304680:Attack [Finding]

Phrase: "the scissile bond."
Processing 00000000.tx.82: The effect of mutating the active site glutamate and histidine has been reported to produce an inactive enzyme (37, 42). 

Phrase: "The effect of mutating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "the active site glutamate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   827   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0205681:Active Site [Functional Concept]

Phrase: "and"

Phrase: "histidine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019602:Histidine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "an inactive enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "(37,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.83: Since we noted varying extents of inactivation when mutating similar residues in the related zinc metallopeptidase puromycin-sensitive aminopeptidase (43), we quantitated the effect of mutating His112 and Glu111 of IDE. 

Phrase: "Since"

Phrase: "we"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "varying extents of inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439792:Extents [Spatial Concept]

Phrase: "when"

Phrase: "mutating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1513776:Mutate [Genetic Function]

Phrase: "similar residues in the related zinc metallopeptidase puromycin-sensitive aminopeptidase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   706   C1709915:Residue [Conceptual Entity]
   706   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(43"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "quantitated"

Phrase: "the effect of mutating His112"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "Glu111 of IDE."
Processing 00000000.tx.84: Two mutants of His112, H112Q and H112D, were generated as well as four mutants of Glu111: E111V, E111L, E111A, and E111F. 

Phrase: "Two mutants of His112,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "H112Q"

Phrase: "and"

Phrase: "H112D,"

Phrase: "were"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "as well as"

Phrase: "four mutants of Glu111"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: ":"

Phrase: "E111V,"

Phrase: "E111L,"

Phrase: "E111A,"

Phrase: "and"

Phrase: "E111F."
Processing 00000000.tx.85: We initially compared the kinetics of the various His112 and Glu111 mutants using the fluorogenic substrate Abz-GGFLRKHGQ-EDDnp. 

Phrase: "We initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the kinetics of the various His112"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0022702:Kinetics [Natural Phenomenon or Process]
   753   C0220865:kinetics [Functional Concept]
   753   C2825046:Kinetics [Occupation or Discipline]

Phrase: "and"

Phrase: "Glu111 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the fluorogenic substrate Abz-GGFLRKHGQ-EDDnp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   884   C1566515:abz-GGFLRKHGQ-EDDnp [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.86: Although native IDE clearly displayed a sigmoidal substrate binding curve (Fig. 1), both of the His112 mutants and all four of the Glu111 mutants displayed classical hyperbolic substrate binding curves as illustrated for the E111F mutant in Fig. 

Phrase: "Although"

Phrase: "native IDE clearly"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "a sigmoidal substrate binding curve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205134:Curve [Spatial Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "both of the His112 mutants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0238767:Both [Spatial Concept]
   760   C0596988:mutants [Cell or Molecular Dysfunction]
   760   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "all four of the Glu111 mutants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205450:Four [Quantitative Concept]
   753   C0444868:All [Quantitative Concept]
   753   C0596988:mutants [Cell or Molecular Dysfunction]
   753   C3539085:All [Idea or Concept]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "classical hyperbolic substrate binding curves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C0205134:Curve [Spatial Concept]

Phrase: "as"

Phrase: "illustrated for the E111F mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.87: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.88: Table II summarizes the kinetic parameters for each of the mutants. 

Phrase: "Table II"

Phrase: "summarizes"

Phrase: "the kinetic parameters for each of the mutants."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0449381:Parameters [Finding]
   711 E C0549193:Parameter [Spatial Concept]
   711 E C1704769:Parameter [Conceptual Entity]
   711 E C2350001:Parameter [Quantitative Concept]
Processing 00000000.tx.89: Both of the His112 mutants exhibited a 35-fold increase in Km, with kcat decreased close to 7,000-fold for the H112D mutant but less than 100-fold for the H112Q mutant. 

Phrase: "Both of the His112 mutants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0238767:Both [Spatial Concept]
   760   C0596988:mutants [Cell or Molecular Dysfunction]
   760   C1706086:Both [Qualitative Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a 35-fold increase in Km,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "with kcat"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "close to 7,000-fold"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0587267:Close [Functional Concept]

Phrase: "for the H112D mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "but"

Phrase: "less than 100-fold"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0439092:Less Than [Intellectual Product]
           less
   770   C0332462:Fold [Spatial Concept]
   770   C0547044:Less [Qualitative Concept]
   770   C1880834:FOLD [Phenomenon or Process]

Phrase: "for the H112Q mutant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]
Processing 00000000.tx.90: Mutation of the active site glutamate to valine, leucine, alanine, or phenylalanine produced enzyme forms in which the effects on Km were variable from essentially no change for the E111L and E111F mutants to a greater than 7-fold increase for the E111A mutant. 

Phrase: "Mutation of the active site glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "to valine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042285:Valine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "leucine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "alanine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "phenylalanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "produced"

Phrase: "enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "forms in which"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0348078:Form [Qualitative Concept]
   790   C0376315:Form [Manufactured Object]
   790   C1522492:Form [Functional Concept]

Phrase: "the effects on Km"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "variable from essentially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439828:Variable [Qualitative Concept]

Phrase: "no change for the E111L"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0442739:No change [Finding]
   806   C1548568:No change [Intellectual Product]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "E111F mutants to a greater"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "than 7-fold increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442805:Increase [Functional Concept]

Phrase: "for the E111A mutant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]
Processing 00000000.tx.91: The range of kcat values for the Glu111 mutants varied from a decrease of 9,000-fold (E111A) to a decrease of 68,000-fold (E111L). 

Phrase: "The range of kcat values"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C1547411:Value range [Idea or Concept]
   760   C1514721:Range [Quantitative Concept]
   760   C2348147:Range [Quantitative Concept]
   760   C3542016:Range [Intellectual Product]

Phrase: "for the Glu111 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "varied from a decrease of 9,000-fold"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0332462:Fold [Spatial Concept]
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]
   744   C1880834:FOLD [Phenomenon or Process]

Phrase: "(E111A"

Phrase: ")"

Phrase: "to a decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "of 68,000-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(E111L"

Phrase: ")."
Processing 00000000.tx.92: View larger version (18K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.93: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.94: Comparison of the kinetics of wild type IDE with the kinetics of the E111F mutant. 

Phrase: "Comparison of the kinetics of wild type IDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1707455:Comparison [Activity]

Phrase: "with the kinetics"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022702:Kinetics [Natural Phenomenon or Process]
  1000   C0220865:kinetics [Functional Concept]
  1000   C2825046:Kinetics [Occupation or Discipline]

Phrase: "of the E111F mutant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]
Processing 00000000.tx.95: Reactions were conducted in 50 mM Tris-HCl, pH 7.4, with wild type IDE (50 ng of enzyme) (top) or the E111F mutant (30 g of enzyme) (bottom) using Abz-GGFLRKHGQEDDnp as the variable substrate.  

Phrase: "Reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "conducted in 50 mM Tris-HCl,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   753   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   753   C0814229:TRI [Intellectual Product]
   719   C0004927:Conduct [Individual Behavior]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "with wild type IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(50 ng of enzyme"

Phrase: ")"

Phrase: "(top)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "or"

Phrase: "the E111F mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(30 g of enzyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C2265200:G enzyme [Molecular Function]
   770   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "(bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Abz-GGFLRKHGQEDDnp as the variable substrate."
Processing 00000000.tx.96: View this table: [in this window] [in a new window]  TABLE II Kinetic properties of IDE mutants with Abz-GGFLRKHGQ-EDDnp as substrate Activity was determined in 20 mM potassium phosphate buffer, pH 7.3.  

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE II Kinetic properties of IDE mutants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   742   C0871161:properties [Qualitative Concept]
   742   C1292721:properties [Functional Concept]
   708 E C1882134:Property [Conceptual Entity]
   708 E C2347695:Property [Entity]

Phrase: "with Abz-GGFLRKHGQ-EDDnp"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1566515:abz-GGFLRKHGQ-EDDnp [Amino Acid, Peptide, or Protein]

Phrase: "as substrate Activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "determined in 20 mM potassium phosphate buffer,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0071778:potassium phosphate [Inorganic Chemical,Pharmacologic Substance]
   778   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C0032821:Potassium [Element, Ion, or Isotope]
   748   C0597277:Potassium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 7.3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0601906:PH 3 [Pharmacologic Substance]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.97: We also examined the effect of the Glu111 and His112 mutations on the hydrolysis of three physiological peptide substrates for IDE, insulin, -endorphin, and amyloid peptide 140. 

Phrase: "We also"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effect of the Glu111"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "His112 mutations on the hydrolysis of three physiological peptide substrates"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0026882:Mutations [Genetic Function]
   706 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "for IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "insulin, -"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "endorphin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014242:Endorphin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C0205752:endorphin [Biologically Active Substance]

Phrase: "and"

Phrase: "amyloid peptide 140."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.98: As shown in Table III, under saturating substrate conditions, -endorphin and amyloid peptide 140 hydrolysis was decreased 107-fold for the Glu111 mutants and 106-fold for the His112 mutants. 

Phrase: "As"

Phrase: "shown in Table III,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039224:Table [Manufactured Object]
   770   C0439070:III [Intellectual Product]
   770   C1705160:III [Qualitative Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]

Phrase: "under saturating substrate conditions, -"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "endorphin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014242:Endorphin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C0205752:endorphin [Biologically Active Substance]

Phrase: "and"

Phrase: "amyloid peptide 140 hydrolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "107-fold for the Glu111 mutants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332462:Fold [Spatial Concept]
   753   C1880834:FOLD [Phenomenon or Process]

Phrase: "and"

Phrase: "106-fold for the His112 mutants."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332462:Fold [Spatial Concept]
   753   C1880834:FOLD [Phenomenon or Process]
Processing 00000000.tx.99: With insulin as substrate, no hydrolysis could be detected with the Glu111 mutants under conditions in which a decrease of 107-fold could have been detected, whereas with the His112 mutants, insulin hydrolysis was decreased 3 x 106-fold (H112Q) to 107-fold (H112D). 

Phrase: "With insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "as substrate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "no hydrolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "could"

Phrase: "be"

Phrase: "detected with the Glu111 mutants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0442726:Detected [Finding]
   760   C0596988:mutants [Cell or Molecular Dysfunction]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "under conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "in which"

Phrase: "a decrease of 107-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "could"

Phrase: "have"

Phrase: "been"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "whereas with the His112 mutants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "insulin hydrolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "3 x 106-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332462:Fold [Spatial Concept]
   812   C1880834:FOLD [Phenomenon or Process]

Phrase: "(H112Q"

Phrase: ")"

Phrase: "to 107-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "(H112D"

Phrase: ")."
Processing 00000000.tx.100: View this table: [in this window] [in a new window]  TABLE III Rates of hydrolysis of physiological peptides by IDE mutants Activity was determined in 50 mM Tris-HCl buffer, pH 7.4, with 10 M peptide. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE III Rates of hydrolysis of physiological peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C0871208:Rate [Activity]
   711   C1521828:Rate [Quantitative Concept]

Phrase: "by IDE mutants Activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   897   C1145751:insulin activity [Molecular Function]
   853   C0243102:enzyme activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "was"

Phrase: "determined in 50 mM Tris-HCl buffer,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   748   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "with 10 M peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.101: Rates of hydrolysis were determined by following substrate disappearance by HPLC.  

Phrase: "Rates of hydrolysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0871208:Rate [Activity]
   756   C1521828:Rate [Quantitative Concept]

Phrase: "were"

Phrase: "determined by following substrate disappearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1710236:Substrate [Manufactured Object]
   726   C0332283:follow [Temporal Concept]
   726   C1719822:Follow [Intellectual Product]

Phrase: "by HPLC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]
Processing 00000000.tx.102: IDE has been found to contain a cationic regulatory site distinct from the active site, which binds nucleotide triphosphates primarily through the triphosphate moiety (44). 

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a cationic regulatory site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "distinct from the active site,"

Phrase: "which"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "nucleotide triphosphates primarily through the triphosphate moiety"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0146894:triphosphate [Inorganic Chemical]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.103: The binding of a polyanion at this site increases the rate with small peptides as substrates, but not with the larger physiological substrates insulin or amyloid peptide. 

Phrase: "The binding of a polyanion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "at this site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the rate with small peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "as substrates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710236:Substrate [Manufactured Object]

Phrase: "but"

Phrase: "not with the larger physiological substrates insulin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0205463:Physiological [Functional Concept]
   748   C0443228:larger [Quantitative Concept]
   748   C0549177:Larger [Quantitative Concept]
   748   C1518422:Not [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1704243:Larger [Quantitative Concept]
   714   C1710236:Substrate [Manufactured Object]

Phrase: "or"

Phrase: "amyloid peptide."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.104: Since the active site histidine and glutamate mutations caused a loss of allosteric interactions, we tested whether the mutant enzymes could still be activated by ATP and triphosphate. 

Phrase: "Since"

Phrase: "the active site histidine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0019602:Histidine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C0205681:Active Site [Functional Concept]

Phrase: "and"

Phrase: "glutamate mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a loss of allosteric interactions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "whether"

Phrase: "the mutant enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]

Phrase: "could"

Phrase: "still"

Phrase: "be"

Phrase: "activated by ATP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "triphosphate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0146894:triphosphate [Inorganic Chemical]
Processing 00000000.tx.105: As shown in Table IV, using Abz-GGFLRKHGQ-EDDnp or dynorphin B-9 as substrate, the Glu111 mutants were activated by ATP to a much lesser extent compared with the wild type enzyme. 

Phrase: "As"

Phrase: "shown in Table IV,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Abz-GGFLRKHGQ-EDDnp"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1566515:abz-GGFLRKHGQ-EDDnp [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "dynorphin B-9 as substrate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0073381:Dynorphin B [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   760   C0013355:Dynorphin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1418447:dynorphin [Gene or Genome]
   760   C1710236:Substrate [Manufactured Object]

Phrase: "the Glu111 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "activated by ATP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]

Phrase: "to a much lesser extent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439792:Extent [Spatial Concept]

Phrase: "compared with the wild type enzyme."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   753   C1707455:Compared [Activity]
Processing 00000000.tx.106: A similar effect was observed with triphosphate as the activator. 

Phrase: "A similar effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "observed with triphosphate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0146894:triphosphate [Inorganic Chemical]
   790   C1441672:Observed [Functional Concept]

Phrase: "as the activator."
Processing 00000000.tx.107: View this table: [in this window] [in a new window]  TABLE IV Effect of ATP and PPPi on mutant IDE activity Activity was determined with 10 M Abz-GGFLRKHGQ-EDDnp or 10 M dynorphin B-9 in 50 mM Tris-HCl buffer, pH 7.4, in the presence of 5 mM ATP or 5 mM PPPi and compared with that in the absence of any addition. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE IV Effect of ATP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "PPPi on mutant IDE activity Activity"

Phrase: "was"

Phrase: "determined with 10 M Abz-GGFLRKHGQ-EDDnp"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C1566515:abz-GGFLRKHGQ-EDDnp [Amino Acid, Peptide, or Protein]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]

Phrase: "or"

Phrase: "10 M dynorphin B-9 in 50 mM Tris-HCl buffer,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   756   C0073381:Dynorphin B [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   754   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   738   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   738   C0013355:Dynorphin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   738   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0441923:M+ [Intellectual Product]
   738   C0814229:TRI [Intellectual Product]
   738   C1418447:dynorphin [Gene or Genome]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 5 mM ATP"

Phrase: "or"

Phrase: "5 mM PPPi"

Phrase: "and"

Phrase: "compared with that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of any addition."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]
Processing 00000000.tx.108: Specific activities in the absence of added ATP or PPPi with Abz-GGFLRKHGQ-EDDnp as substrate were as follows: wild type IDE = 8,131 nmol/min/mg; 

Phrase: "Specific activities in the absence of added ATP"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   744   C0205369:Specific [Qualitative Concept]
   744   C0441655:Activities [Activity]
   744   C1552740:specific [Intellectual Product]
   711 E C0205177:Activity [Functional Concept]
   711 E C0439167:% activity [Quantitative Concept]
   711 E C1561536:*Activity [Idea or Concept]

Phrase: "or"

Phrase: "PPPi with Abz-GGFLRKHGQ-EDDnp"

Phrase: "as substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "wild type IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "= 8,131 nmol/min/mg"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C0439291:nmol/mg [Quantitative Concept]
   804   C0439269:mg% [Quantitative Concept]
   804   C1960952:mg % [Quantitative Concept]
   804   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.109: E111A, 7.5 nmol/min/mg; 

Phrase: "E111A,"

Phrase: "7.5 nmol/min/mg"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C0439291:nmol/mg [Quantitative Concept]
   804   C0439269:mg% [Quantitative Concept]
   804   C1960952:mg % [Quantitative Concept]
   804   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.110: E111V, 2.7 nmol/min/mg; 

Phrase: "E111V,"

Phrase: "2.7 nmol/min/mg"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C0439291:nmol/mg [Quantitative Concept]
   804   C0439269:mg% [Quantitative Concept]
   804   C1960952:mg % [Quantitative Concept]
   804   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.111: E111F, 5.2 nmol/min/mg; 

Phrase: "E111F,"

Phrase: "5.2 nmol/min/mg"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C0439291:nmol/mg [Quantitative Concept]
   804   C0439269:mg% [Quantitative Concept]
   804   C1960952:mg % [Quantitative Concept]
   804   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.112: E111L, 0.092 nmol/min/mg; 

Phrase: "E111L,"

Phrase: "0.092 nmol/min/mg"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C0439291:nmol/mg [Quantitative Concept]
   804   C0439269:mg% [Quantitative Concept]
   804   C1960952:mg % [Quantitative Concept]
   804   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.113: H112D, 28.1 nmol/min/mg; 

Phrase: "H112D,"

Phrase: "28.1 nmol/min/mg"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C0439291:nmol/mg [Quantitative Concept]
   804   C0439269:mg% [Quantitative Concept]
   804   C1960952:mg % [Quantitative Concept]
   804   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.114: H112Q, 847 nmol/min/mg.  

Phrase: "H112Q,"

Phrase: "847 nmol/min/mg."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0439291:nmol/mg [Quantitative Concept]
   812   C0439269:mg% [Quantitative Concept]
   812   C1960952:mg % [Quantitative Concept]
   812   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.115: The His112 mutants were affected differently by ATP and triphosphate, which acted as inhibitors rather than activators. 

Phrase: "The His112 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "differently by ATP"

Phrase: "and"

Phrase: "triphosphate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0146894:triphosphate [Inorganic Chemical]

Phrase: "which"

Phrase: "acted as inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0243077:inhibitors [Chemical Viewed Functionally]
   756   C0079613:ACT [Therapeutic or Preventive Procedure]
   756 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "rather than"

Phrase: "activators."
Processing 00000000.tx.116: With the H112Q mutant, triphosphate was an effective inhibitor of Abz-GGFLRKHGQ-EDDnp hydrolysis at micromolar concentrations ( M; M), whereas activation of the wild type enzyme required millimolar concentrations ( mM, mM); 

Phrase: "With the H112Q mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "triphosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0146894:triphosphate [Inorganic Chemical]

Phrase: "was"

Phrase: "an effective inhibitor of Abz-GGFLRKHGQ-EDDnp hydrolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1999216:Inhibitor [Qualitative Concept]

Phrase: "at micromolar concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "( M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: ";"

Phrase: "M)"

Phrase: ","

Phrase: "whereas"

Phrase: "activation of the wild type enzyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0014429:Enzyme Activation [Molecular Function]
   753   C1879547:Activation [Activity]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "millimolar concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "( mM,"

Phrase: "mM"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.117: this is illustrated in Fig. 

Phrase: "this"

Phrase: "is"

Phrase: "illustrated in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.118: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.119: View larger version (15K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.120: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.121: Comparison of the effect of triphosphate on the hydrolysis of Abz-GGFLRKHGQ-EDDnp by wild type IDE (top) with the IDE H112Q mutant (bottom). 

Phrase: "Comparison of the effect of triphosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707455:Comparison [Activity]

Phrase: "on the hydrolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "of Abz-GGFLRKHGQ-EDDnp"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1566515:abz-GGFLRKHGQ-EDDnp [Amino Acid, Peptide, or Protein]

Phrase: "by wild type IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(top) with the IDE H112Q mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1704458:Top [Spatial Concept]

Phrase: "(bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.122: Activity was determined in 50 mM Tris-HCl buffer, pH 7.4, with 10 M Abz-GGFLRKHGQ-EDDnp as substrate and the indicated concentration of PPPi. 

Phrase: "Activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "determined in 50 mM Tris-HCl buffer,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   748   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "with 10 M Abz-GGFLRKHGQ-EDDnp"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   884   C1566515:abz-GGFLRKHGQ-EDDnp [Amino Acid, Peptide, or Protein]

Phrase: "as substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "and"

Phrase: "the indicated concentration of PPPi."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.123: The reactions with wild type enzyme contained 50 ng of protein, whereas those with the H112Q mutant contained 10 g of protein. 

Phrase: "The reactions with wild type enzyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0443286:Reaction [Functional Concept]
   719   C1114821:Reaction [Clinical Attribute]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "50 ng of protein,"

Phrase: "whereas"

Phrase: "those with the H112Q mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "10 g of protein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0060916:protein g [Amino Acid, Peptide, or Protein]
   819   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.124: For the wild type enzyme, the activity in the absence of added PPPi was 0.35 nmol/min. 

Phrase: "For the wild type enzyme,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "the activity in the absence of added PPPi"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "0.35 nmol/min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827910:nmol/min [Quantitative Concept]
   812   C0702093:/min [Temporal Concept]
Processing 00000000.tx.125: Although not shown, there was no effect of PPPi on the activity of the wild type enzyme over the same concentration range used for the H112Q mutant.  

Phrase: "Although"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ","

Phrase: "there"

Phrase: "was"

Phrase: "no effect of PPPi"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1301751:No effect [Qualitative Concept]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on the activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "of the wild type enzyme"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "over the same concentration range"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   827   C1514721:Range [Quantitative Concept]
   827   C2348147:Range [Quantitative Concept]
   827   C3542016:Range [Intellectual Product]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "used for the H112Q mutant."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.126: We used sedimentation equilibrium to determine what if any effect the active site mutations had on IDE oligomerization (Fig. 3). 

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "sedimentation equilibrium to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0597429:sedimentation equilibrium [Natural Phenomenon or Process]
   827   C0014653:Equilibrium [Organism Function]
   827   C1547026:Equilibrium [Quantitative Concept]

Phrase: "determine"

Phrase: "what"

Phrase: "if"

Phrase: "any effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "the active site mutations"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0205681:Active Site [Functional Concept]
   827   C0026882:Mutations [Genetic Function]
   827   C0205145:Site [Spatial Concept]
   827   C0205177:Active [Functional Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "had on IDE oligomerization"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0062074:HAD [Therapeutic or Preventive Procedure]
   753   C1415458:HAD [Gene or Genome]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C3539897:Had [Qualitative Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.127: We previously reported that in Tris buffer, the wild type enzyme appeared predominantly as a mixture of monomers and dimers (44). 

Phrase: "We previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that in Tris buffer,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   770   C0814229:TRI [Intellectual Product]

Phrase: "the wild type enzyme"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "predominantly as a mixture of monomers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439962:Mixture [Substance]
   753   C0596973:monomers [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "dimers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596448:dimers [Chemical Viewed Structurally]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.128: The monomer was the predominant species. 

Phrase: "The monomer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "was"

Phrase: "the predominant species."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.129: The addition of 4 mM triphosphate maintained the monomer as the dominant species but eliminated the small amount of dimers (44). 

Phrase: "The addition of 4 mM triphosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1883712:Addition [Functional Concept]

Phrase: "maintained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]

Phrase: "the monomer as the dominant species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "but"

Phrase: "eliminated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]

Phrase: "the small amount of dimers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.130: In this study, we found that the H112Q mutant appeared monomeric with a trace of a higher aggregate, possibly the tetramer, present. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the H112Q mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "monomeric with a trace of a higher aggregate,"

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "the tetramer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039686:Tetramere [Eukaryote]

Phrase: "present."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]
Processing 00000000.tx.131: The addition of PPPi decreased solubility but did not significantly change the distribution of oligomeric species. 

Phrase: "The addition of PPPi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "solubility"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0037628:Solubility [Qualitative Concept]
   928 E C1749467:soluble [Cell Component]
   928 E C1948047:Soluble [Qualitative Concept]

Phrase: "but"

Phrase: "did"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "the distribution of oligomeric species."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]
Processing 00000000.tx.132: In contrast, the H112D mutant appeared less soluble but showed predominantly tetramers. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the H112D mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "less soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1749467:soluble [Cell Component]
   861   C1948047:Soluble [Qualitative Concept]

Phrase: "but"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "predominantly tetramers."
Processing 00000000.tx.133: The addition of PPPi decreased solubility but clearly showed the presence of primarily monomers with higher aggregates present. 

Phrase: "The addition of PPPi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "solubility"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0037628:Solubility [Qualitative Concept]
   928 E C1749467:soluble [Cell Component]
   928 E C1948047:Soluble [Qualitative Concept]

Phrase: "but"

Phrase: "clearly"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the presence of primarily monomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "with higher aggregates present."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0150312:Present [Quantitative Concept]
   827   C0449450:Present [Idea or Concept]
Processing 00000000.tx.134: E111A, E111F, and E111L all appeared as monomers with a trace of tetramer present. 

Phrase: "E111A,"

Phrase: "E111F,"

Phrase: "and"

Phrase: "E111L"

Phrase: "all"

Phrase: "appeared as monomers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0596973:monomers [Chemical Viewed Structurally]
   756   C0700364:APPEAR [Qualitative Concept]

Phrase: "with a trace"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0442822:Trace [Quantitative Concept]
  1000   C1524031:Trace [Qualitative Concept]
  1000   C1883002:Trace [Functional Concept]

Phrase: "of tetramer present."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
Processing 00000000.tx.135: E111V exhibited poor solubility and could not be analyzed. 

Phrase: "E111V"

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "poor solubility"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0037628:Solubility [Qualitative Concept]
   789 E C1749467:soluble [Cell Component]
   789 E C1948047:Soluble [Qualitative Concept]

Phrase: "and"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.136: The addition of PPPi to E111L and E111A had no effect on the distribution of species but induced some aggregation with E111A and complete aggregation of E111F. 

Phrase: "The addition of PPPi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "to E111L"

Phrase: "and"

Phrase: "E111A"

Phrase: "had"

Phrase: "no effect on the distribution of species"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1301751:No effect [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "but"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "some aggregation with E111A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]

Phrase: "and"

Phrase: "complete aggregation of E111F."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]
Processing 00000000.tx.137: Thus, there is no clear correlation between oligomeric state and enzyme activity. 

Phrase: "Thus,"

Phrase: "there"

Phrase: "is"

Phrase: "no clear correlation between oligomeric state"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "enzyme activity."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0243102:enzyme activity [Molecular Function]
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
   777 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.138: View larger version (26K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.139: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.140: Sedimentation equilibrium analysis of wild type and E111A mutant IDE proteins. 

Phrase: "Sedimentation equilibrium analysis of wild type"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "E111A mutant IDE proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   876   C1564139:Mutant Proteins [Amino Acid, Peptide, or Protein]
   799   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.141: Samples were dissolved in 50 mM Tris-HCl buffer, pH 7.4, and brought to sedimentation equilibrium at 10,000 rpm and 4 C. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "dissolved in 50 mM Tris-HCl buffer,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   748   C0814229:TRI [Intellectual Product]
   714   C1549535:Dissolve [Functional Concept]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "brought to sedimentation equilibrium"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0597429:sedimentation equilibrium [Natural Phenomenon or Process]
   770   C0014653:Equilibrium [Organism Function]
   770   C0332302:brought [Functional Concept]
   770   C0597428:Sedimentation [Laboratory Procedure]
   770   C1384604:Sedimentation [Natural Phenomenon or Process]
   770   C1547026:Equilibrium [Quantitative Concept]

Phrase: "at 10,000 rpm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0582523:rpm [Quantitative Concept]

Phrase: "and"

Phrase: "4 C."
Processing 00000000.tx.142: Open circles, wild type IDE; 

Phrase: "Open circles,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1282913:Circle [Spatial Concept]
   827   C1551714:Circle [Population Group]

Phrase: "wild type IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.143: filled circles, E111A mutant IDE. 

Phrase: "filled circles,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1282913:Circle [Spatial Concept]
   827   C1551714:Circle [Population Group]

Phrase: "E111A mutant IDE."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.144: The smooth curves represent global fits of Equation 1 to data sets obtained at 10,000, 15,000, and 20,000 rpm. 

Phrase: "The smooth curves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205134:Curve [Spatial Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "global fits of Equation 1"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   781   C1416400:FIT-1 [Gene or Genome]
   760   C0036572:Fits NOS [Sign or Symptom]
   726 E C0424576:Fit [Finding]
   726 E C2349186:Fit [Activity]

Phrase: "to data sets"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0150098:data sets [Intellectual Product]
   861   C0036849:Set [Mental Process]
   861   C1442518:Set [Functional Concept]
   861   C1511726:Data [Idea or Concept]
   861   C1705195:Set [Conceptual Entity]
   861   C3245479:data [Medical Device]

Phrase: "obtained at 10,000,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "15,000,"

Phrase: "and"

Phrase: "20,000 rpm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0582523:rpm [Quantitative Concept]
Processing 00000000.tx.145: The small, symmetric residuals demonstrate the compatibility of this equation with the data. 

Phrase: "The small, symmetric residuals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1609982:residuals [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "the compatibility of this equation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237519:compatibility [Qualitative Concept]
   760   C1881693:COMPATIBILITY [Event]

Phrase: "with the data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]
Processing 00000000.tx.146: The data for both the wild type and mutant IDE are consistent with mixtures in which monomeric enzyme predominates over relatively small mol fractions of higher oligomers.  

Phrase: "The data for both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "the wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "mutant IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "are"

Phrase: "consistent with mixtures"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "in which monomeric enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "predominates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332251:Predominate [Qualitative Concept]

Phrase: "over relatively small mol fractions of higher oligomers."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   754   C1264633:Fraction of [Quantitative Concept]
           Fractions
   744   C0027960:Mole [Neoplastic Process]
   744   C0324740:Mole [Mammal]
   744   C0439189:Mole [Quantitative Concept]
   744   C1456781:mole [Neoplastic Process]
   744   C1824986:mol [Gene or Genome]
   711 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.147: Perlman et al. 

Phrase: "Perlman et al."
Processing 00000000.tx.148: (42) showed that His112 is a zinc-coordinating residue and provided evidence that the active site zinc was lost in the H112Q mutant. 

Phrase: "(42"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that His112"

Phrase: "is"

Phrase: "a zinc-coordinating residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   755 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "provided evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the active site zinc"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C2348288:Zinc [Element, Ion, or Isotope]
   734   C0205681:Active Site [Functional Concept]

Phrase: "was"

Phrase: "lost in the H112Q mutant."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   760   C0745777:Lost [Functional Concept]
Processing 00000000.tx.149: We reexamined this issue with both the H112Q and H112D mutants. 

Phrase: "We"

Phrase: "reexamined"

Phrase: "this issue with both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033213:Issue [Finding]
   770   C1706387:Issue [Intellectual Product]

Phrase: "the H112Q"

Phrase: "and"

Phrase: "H112D mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.150: To accomplish this we looked at the ability of EDTA and o-phenanthroline to inhibit the residual activity of these mutants. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "accomplish"

Phrase: "this we"

Phrase: "looked at the ability of EDTA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   753   C0085732:Ability [Organism Attribute]
   719   C0233426:look [Organism Attribute]

Phrase: "and"

Phrase: "o-phenanthroline to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0087870:o-phenanthroline [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   827   C0031370:phenanthroline [Organic Chemical]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the residual activity of these mutants."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.151: As shown in Table V, inclusion of 0.1 mM EDTA or 0.1 mM o-phenanthroline in the assay had little effect on the activity of wild type IDE. 

Phrase: "As"

Phrase: "shown in Table V,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]

Phrase: "inclusion of 0.1 mM EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1512693:Inclusion [Qualitative Concept]

Phrase: "or"

Phrase: "0.1 mM o-phenanthroline in the assay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0031370:phenanthroline [Organic Chemical]

Phrase: "had"

Phrase: "little effect on the activity of wild type IDE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1280500:Effect [Qualitative Concept]
   738   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.152: Similarly, 0.1 mM EDTA or 0.1 mM o-phenanthroline had no effect on the rate of insulin hydrolysis by the glutamate mutants (data not shown). 

Phrase: "Similarly,"

Phrase: "0.1 mM EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "0.1 mM o-phenanthroline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0031370:phenanthroline [Organic Chemical]

Phrase: "had"

Phrase: "no effect on the rate of insulin hydrolysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1301751:No effect [Qualitative Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "by the glutamate mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.153: In contrast, both metal-chelating agents completely inhibited the activity of the histidine mutants as shown in Table V. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "both metal-chelating agents completely"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   906   C3537172:Metal Chelating Agent [Pharmacologic Substance]
   861   C0007974:Chelating Agents [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C3537131:Chelating [Molecular Function]
   779   C0450442:Agent [Chemical Viewed Functionally]
   779   C1254351:Agent [Pharmacologic Substance]
   779   C1521826:Agent [Intellectual Product]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the activity of the histidine mutants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "as"

Phrase: "shown in Table V."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.154: Although not shown, significant inhibition of the wild type enzyme and glutamate mutants was observed with higher concentrations of EDTA (1 mM) and o-phenanthroline (1 mM). 

Phrase: "Although"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ","

Phrase: "significant inhibition of the wild type enzyme"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0877008:enzyme inhibition [Disease or Syndrome]
   774   C1524081:Enzyme Inhibition [Physiologic Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "and"

Phrase: "glutamate mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "observed with higher concentrations of EDTA (1 mM)"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   767   C1418486:MM-1 [Gene or Genome]
   744   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   744   C0086045:Concentrations [Mental Process]
   744   C1441672:Observed [Functional Concept]
   711   C0205250:High [Qualitative Concept]
   711   C1299351:High [Qualitative Concept]
   711 E C1446561:Concentration [Quantitative Concept]
   711   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "o-phenanthroline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0087870:o-phenanthroline [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "(1 mM"

Phrase: ")."
Processing 00000000.tx.155: Thus, the His112 mutants appear to retain active site zinc, but this zinc is bound more weakly. 

Phrase: "Thus,"

Phrase: "the His112 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "retain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "active site zinc,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C2348288:Zinc [Element, Ion, or Isotope]
   734   C0205681:Active Site [Functional Concept]

Phrase: "but"

Phrase: "this zinc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "is"

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "more weakly."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]
Processing 00000000.tx.156: We thus looked at the ability of zinc to increase the reaction rate of the His mutants. 

Phrase: "We thus"

Phrase: "looked at the ability of zinc to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0085732:Ability [Organism Attribute]
   748   C2348288:Zinc [Element, Ion, or Isotope]
   714   C0233426:look [Organism Attribute]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the reaction rate of the"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0678608:reaction rate [Temporal Concept]
   760   C0443286:Reaction [Functional Concept]
   760   C0871208:Rate [Activity]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "His mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.157: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.158: 4, the addition of zinc over the concentration range of 0.110 M caused a maximal 1.8-fold increase in the activity of the H112Q mutant and a 1.2-fold increase in the activity of the H112D mutant. 

Phrase: "4,"

Phrase: "the addition of zinc"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "over the concentration range"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 0.110 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a maximal 1.8-fold increase in the activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "of the H112Q mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "a 1.2-fold increase in the activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "of the H112D mutant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]
Processing 00000000.tx.159: This was followed by inhibition at higher zinc concentrations. 

Phrase: "This"

Phrase: "was"

Phrase: "followed by inhibition"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C3463820:Inhibition [Activity]
   756 E C1719822:Follow [Intellectual Product]
   718 E C0311403:Inhibited [Qualitative Concept]

Phrase: "at higher zinc concentrations."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.160: In contrast, zinc, at all concentrations tested, was slightly inhibitory of the wild type activity. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "zinc,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "at all concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ","

Phrase: "was"

Phrase: "slightly inhibitory of the wild type activity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3463820:Inhibitory [Activity]
Processing 00000000.tx.161: View this table: [in this window] [in a new window]  TABLE V Effect of metal chelators on mutant IDE activity Activity was determined in 50 mM Tris-HCl, pH 7.4, with either 10 M Abz-GGFLRKHGQ-EDDnp as substrate or 10 M insulin (values in parenthesis) as substrate and 0.1 mM EDTA or 0.1 mM o-phenanthroline added as indicated.  

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE V Effect of metal chelators"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on mutant IDE activity Activity"

Phrase: "was"

Phrase: "determined in 50 mM Tris-HCl,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   753   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   753   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "with either 10 M Abz-GGFLRKHGQ-EDDnp"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1566515:abz-GGFLRKHGQ-EDDnp [Amino Acid, Peptide, or Protein]

Phrase: "as substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "or"

Phrase: "10 M insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(values in parenthesis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0042295:Values [Qualitative Concept]
   756 E C1522609:Value [Quantitative Concept]

Phrase: ")"

Phrase: "as"

Phrase: "substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "and"

Phrase: "0.1 mM EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "0.1 mM o-phenanthroline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0031370:phenanthroline [Organic Chemical]

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.162: View larger version (11K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(11K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.163: 4. 

Phrase: "4."
Processing 00000000.tx.164: The effect of zinc on the activity of wild type IDE and its His112 mutants. 

Phrase: "The effect of zinc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on the activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "of wild type IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "its His112 mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.165: Activity was determined in 50 mM Tris-HCl buffer, pH 7.4, with 10 M Abz-GGFLRKHGQ-EDDnp as substrate and the indicated concentration of ZnCl2.  

Phrase: "Activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "determined in 50 mM Tris-HCl buffer,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   748   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "with 10 M Abz-GGFLRKHGQ-EDDnp"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   884   C1566515:abz-GGFLRKHGQ-EDDnp [Amino Acid, Peptide, or Protein]

Phrase: "as substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "and"

Phrase: "the indicated concentration of ZnCl2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.166: In order to determine whether the mutations introduced into IDE affected enzyme specificity, we looked at the cleavage pattern of three physiological peptides, -endorphin, insulin, and amyloid peptide 140 using each of the mutants listed in Table II. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "introduced into IDE"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726   C1292748:introduce [Functional Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "enzyme specificity,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0678612:enzyme specificity [Natural Phenomenon or Process]
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "we"

Phrase: "looked at the cleavage pattern of three physiological peptides, -"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0010813:cleavage [Cell Function]
   742   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   742   C0205449:Three [Quantitative Concept]
   742   C0205463:Physiological [Functional Concept]
   742   C0449774:Pattern [Spatial Concept]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C1330957:cleavage [Cell Function]
   708   C0233426:look [Organism Attribute]

Phrase: "endorphin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014242:Endorphin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C0205752:endorphin [Biologically Active Substance]

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amyloid peptide 140"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "each of the mutants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0596988:mutants [Cell or Molecular Dysfunction]
   770   C1457900:Each [Quantitative Concept]

Phrase: "listed in Table II."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C0745732:List [Conceptual Entity]
   737   C3272378:LIST [Intellectual Product]
Processing 00000000.tx.167: With insulin and amyloid peptide 140 as substrate, we observed the same initial cleavage products with the various mutants and wild type enzyme. 

Phrase: "With insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amyloid peptide 140 as substrate,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1710236:Substrate [Manufactured Object]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "the same initial cleavage products with the various mutants"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   742   C0010813:cleavage [Cell Function]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C1330957:cleavage [Cell Function]
   742   C1514468:Products [Entity]
   708 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "wild type enzyme."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.168: This is illustrated for insulin cleavage by the E111F mutant in Fig. 

Phrase: "This"

Phrase: "is"

Phrase: "illustrated for insulin cleavage"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0010813:cleavage [Cell Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "by the E111F mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.169: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.170: As previously noted (32), native IDE cleaved -endorphin at the Thr17-Leu18 and Leu18-Phe19 bonds, and the two histidine mutants produced the same cleavage pattern. 

Phrase: "As"

Phrase: "previously"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "(32"

Phrase: ")"

Phrase: ","

Phrase: "native IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "cleaved -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: "endorphin at the Thr17-Leu18"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0014242:Endorphin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   760   C0205752:endorphin [Biologically Active Substance]

Phrase: "and"

Phrase: "Leu18-Phe19 bonds,"

Phrase: "and"

Phrase: "the two histidine mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "produced"

Phrase: "the same cleavage pattern."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449774:Pattern [Spatial Concept]
Processing 00000000.tx.171: However, each of the glutamate 111 mutants produced, in addition to cleavage at Leu17-Phe18 and Phe18-Lys19, cleavage at Lys19-Asn20 and at Met5-Thr6. 

Phrase: "However,"

Phrase: "each of the glutamate 111 mutants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   753   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0596988:mutants [Cell or Molecular Dysfunction]
   753   C1457900:Each [Quantitative Concept]

Phrase: "produced"

Phrase: ","

Phrase: "in addition to cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "at Leu17-Phe18"

Phrase: "and"

Phrase: "Phe18-Lys19,"

Phrase: "cleavage at Lys19-Asn20"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "and at Met5-Thr6."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]
Processing 00000000.tx.172: This is illustrated in Fig. 

Phrase: "This"

Phrase: "is"

Phrase: "illustrated in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.173: 5 for the E111F mutant. 

Phrase: "5 for the E111F mutant."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439084:>5 [Quantitative Concept]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   760   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.174: Based on this result, we also compared the cleavage of small dynorphin-related peptides by native IDE and by the E111V mutant. 

Phrase: "Based on this result,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C1274040:Result [Functional Concept]
   770   C1527178:Based [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C1705938:Based [Idea or Concept]
   770   C2825142:Result [Finding]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "we also"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the cleavage of small dynorphin-related peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "by native IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and by the E111V mutant."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   760   C1515981:And [Idea or Concept]
Processing 00000000.tx.175: We found that with dynorphin A-9, dynorphin A-10, dynorphin A-17, and dynorphin B-9, there was no change in cleavage site. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that with dynorphin A-9,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0086191:Dynorphin A [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   760   C0013355:Dynorphin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1418447:dynorphin [Gene or Genome]

Phrase: "dynorphin A-10,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0086191:Dynorphin A [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0013355:Dynorphin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418447:dynorphin [Gene or Genome]

Phrase: "dynorphin A-17,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0086191:Dynorphin A [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0013355:Dynorphin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418447:dynorphin [Gene or Genome]

Phrase: "and"

Phrase: "dynorphin B-9,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0073381:Dynorphin B [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   827   C0013355:Dynorphin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418447:dynorphin [Gene or Genome]

Phrase: "there"

Phrase: "was"

Phrase: "no change in cleavage site."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0442739:No change [Finding]
   806   C1548568:No change [Intellectual Product]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]
Processing 00000000.tx.176: View larger version (20K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.177: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.178: HPLC chromatograms showing the cleavage of -endorphin and insulin by IDE and its E111F mutant. 

Phrase: "HPLC chromatograms"

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the cleavage of -endorphin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014242:Endorphin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0205752:endorphin [Biologically Active Substance]

Phrase: "and"

Phrase: "insulin by IDE"

Phrase: "and"

Phrase: "its E111F mutant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]
Processing 00000000.tx.179: Top, reaction mixtures containing 10 M insulin in 50 mM Tris-HCl, pH 7.4 (A), were reacted with wild type IDE (0.1 g for 30 min) (B) or E112Q (50 g for 1 h) (C). 

Phrase: "Top,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "reaction mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:mixtures [Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10 M insulin in 50 mM Tris-HCl,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "reacted with wild type IDE"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   814   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   778   C1883559:Wild Type [Organism Attribute]
   774   C0457592:Insulin type [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1547052:*Type [Quantitative Concept]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "(0.1 g for 30 min) ("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0560021:g/min [Quantitative Concept]
   783   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   753   C0439267:g% [Quantitative Concept]

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "or"

Phrase: "E112Q"

Phrase: "(50 g for 1 h) (C)."
Processing 00000000.tx.180: Reaction products were separated by gradient HPLC on a Vydac C4 reverse phase column as described under "Materials and Methods." 

Phrase: "Reaction products"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "separated by gradient HPLC"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0008562:HPLC [Laboratory Procedure]
   770   C0086972:Separated [Finding]
   770   C0439182:% gradient [Quantitative Concept]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C0812409:Gradient [Quantitative Concept]

Phrase: "on a Vydac C4 reverse phase column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1185738:Column [Body Part, Organ, or Organ Component]
   804   C1706132:Column [Idea or Concept]

Phrase: "as"

Phrase: "described under ""Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.181: Product peaks were collected and identified by mass spectrometry. 

Phrase: "Product peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:peaks [Quantitative Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "identified by mass spectrometry."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0037813:Mass Spectrometry [Laboratory Procedure]
   770   C0205396:Identified [Qualitative Concept]
   770   C0436196:Spectrometry [Laboratory Procedure]
   770   C0577559:Mass [Finding]
   770   C1306372:*Mass [Quantitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   770   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.182: Peak 1, insulin B19; 

Phrase: "Peak 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "insulin B19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3470196:B19 [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.183: peak 2, insulin B110; 

Phrase: "peak 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "insulin B110"

Phrase: ";"
Processing 00000000.tx.184: peak 3, insulin A113; 

Phrase: "peak 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "insulin A113"

Phrase: ";"
Processing 00000000.tx.185: peak 4, insulin A114; 

Phrase: "peak 4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "insulin A114"

Phrase: ";"
Processing 00000000.tx.186: peak a, insulin A chain; 

Phrase: "peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444505:Peak [Quantitative Concept]

Phrase: "a,"

Phrase: "insulin A chain"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0021642:Insulin A Chain [Amino Acid, Peptide, or Protein,Hormone]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.187: peak b, insulin B chain. 

Phrase: "peak b,"

Phrase: "insulin B chain."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.188: Bottom, reaction mixtures as above containing 10 M -endorphin (A) reacted with wild type IDE (0.1 g for 15 min) (B) or E111F (50 g for 1 h) (C). 

Phrase: "Bottom,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: "reaction mixtures as above containing 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439962:mixtures [Substance]

Phrase: "M -"

Phrase: "endorphin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014242:Endorphin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C0205752:endorphin [Biologically Active Substance]

Phrase: "(A)"

Phrase: "reacted with wild type IDE"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   814   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   778   C1883559:Wild Type [Organism Attribute]
   774   C0457592:Insulin type [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1547052:*Type [Quantitative Concept]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "(0.1 g for 15 min) ("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0560021:g/min [Quantitative Concept]
   783   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   753   C0439267:g% [Quantitative Concept]

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "or"

Phrase: "E111F"

Phrase: "(50 g for 1 h) (C)."
Processing 00000000.tx.189: Peak 1, -endorphin 1931; 

Phrase: "Peak 1, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "endorphin 1931"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014242:Endorphin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0205752:endorphin [Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.190: peak 2, -endorphin 1831; 

Phrase: "peak 2, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "endorphin 1831"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014242:Endorphin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0205752:endorphin [Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.191: peak 3, -endorphin 117; 

Phrase: "peak 3, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "endorphin 117"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014242:Endorphin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0205752:endorphin [Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.192: peak 4, -endorphin 118; 

Phrase: "peak 4, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "endorphin 118"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014242:Endorphin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0205752:endorphin [Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.193: peak 5, -endorphin 2031; 

Phrase: "peak 5, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "endorphin 2031"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014242:Endorphin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0205752:endorphin [Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.194: peak 6, -endorphin 119; 

Phrase: "peak 6, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "endorphin 119"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014242:Endorphin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0205752:endorphin [Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.195: peak 7, -endorphin 631.   

Phrase: "peak 7, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "endorphin 631."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014242:Endorphin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0205752:endorphin [Biologically Active Substance]
Processing 00000000.tx.196: DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Mutation of residues within the active site motif (HEXXHor HXXEH) of zinc metallopeptidases has been reported to lead to a loss of catalytic activity. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Mutation of residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026882:Mutation [Genetic Function]
   790   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "within the active site motif"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1514562:Motif [Amino Acid Sequence]
   734   C0205681:Active Site [Functional Concept]

Phrase: "(HEXXHor HXXEH"

Phrase: ")"

Phrase: "of zinc metallopeptidases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025543:Metallopeptidases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "lead to a loss of catalytic activity."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   778   C0243102:catalytic activity [Molecular Function]
   778   C1264638:Catalytic activity [Functional Concept]
   778   C1547012:*Catalytic Activity [Quantitative Concept]
   748   C0007382:Catalytic [Natural Phenomenon or Process]
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1517945:Loss [Quantitative Concept]
   748   C1522538:Lead [Functional Concept]
   748   C1561536:*Activity [Idea or Concept]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.197: However, in most cases, the presence of residual activity has not been quantified, generally because of the lack of availability of large amounts of mutant protein. 

Phrase: "However,"

Phrase: "in most cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "the presence of residual activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "quantified"

Phrase: ","

Phrase: "generally because of the lack of availability of large amounts of mutant protein."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   750   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   749   C0470187:Availability of [Functional Concept]
           Availability
   735   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C0332268:lack [Qualitative Concept]
   735   C0549177:Large [Quantitative Concept]
   735   C0596988:Mutant [Cell or Molecular Dysfunction]
   735   C1265611:amounts [Quantitative Concept]
Processing 00000000.tx.198: In most cases, the active site glutamate has been mutated (4549), and although the mutant enzyme is reported to be catalytically inactive, when determined, the inactive enzyme retains the ability to bind substrate (37, 42, 43, 45). 

Phrase: "In most cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "the active site glutamate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   827   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0205681:Active Site [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "(4549"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "although"

Phrase: "the mutant enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "is"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "catalytically inactive,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205254:Inactive [Qualitative Concept]

Phrase: "when"

Phrase: "determined"

Phrase: ","

Phrase: "the inactive enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "retains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "(37,"

Phrase: "42,"

Phrase: "43,"

Phrase: "45"

Phrase: ")."
Processing 00000000.tx.199: The active site glutamate (Glu111) and the active site histidine (His112) of IDE have previously been mutated (37, 42). 

Phrase: "The active site glutamate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   827   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0205681:Active Site [Functional Concept]

Phrase: "(Glu111"

Phrase: ")"

Phrase: "and"

Phrase: "the active site histidine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0019602:Histidine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C0205681:Active Site [Functional Concept]

Phrase: "(His112"

Phrase: ")"

Phrase: "of IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "have"

Phrase: "previously"

Phrase: "been"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "(37,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.200: The His112 mutant transiently expressed in COS cells appeared to be inactive as measured in crude extracts with insulin as substrate. 

Phrase: "The His112 mutant transiently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "expressed in COS cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0376702:COS Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0454802:Cos [Geographic Area]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "inactive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205254:Inactive [Qualitative Concept]

Phrase: "as"

Phrase: "measured in crude extracts"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C1258023:Crude Extracts [Chemical]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737   C2828366:Extract [Substance]

Phrase: "with insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "as substrate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.201: However, this mutant retained the ability to bind insulin as determined by cross-linking studies (37). 

Phrase: "However,"

Phrase: "this mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "retained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retained [Functional Concept]

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "as"

Phrase: "determined by"

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.202: It should be noted that insulin cross-linking was actually increased with the mutant relative to the wild type enzyme and was attributed to a "relaxation of a rigid conformation stabilized by zinc." 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "was"

Phrase: "actually"

Phrase: "increased with the mutant relative"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0080103:Relative [Family Group]
   760   C0205217:Increased [Quantitative Concept]
   760   C0205345:Relative [Qualitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: "to the wild type enzyme"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "was"

Phrase: "attributed to a ""relaxation of a rigid conformation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0026377:Conformation [Spatial Concept]
   744   C0026837:Rigid [Sign or Symptom]
   744   C0035028:Relaxation [Activity]
   744   C0231517:Rigid [Individual Behavior]
   744   C1882952:RIGID [Phenomenon or Process]
   711   C0449234:Attribute [Idea or Concept]
   711   C1704772:Attribute [Conceptual Entity]
   711   C1882133:Attribute [Qualitative Concept]

Phrase: "stabilized by zinc."""
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   790   C0184512:Stabilized [Qualitative Concept]
   790   C2348288:Zinc [Element, Ion, or Isotope]
Processing 00000000.tx.203: Evidence for this increased flexibility at the active site came from the demonstration that treatment of the native enzyme with o-phenanthroline increased the extent of cross-linking; 

Phrase: "Evidence for this increased flexibility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "at the active site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205681:Active Site [Functional Concept]
   861   C0205145:Site [Spatial Concept]
   861   C0205177:Active [Functional Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "came from the demonstration"

Phrase: "that treatment of the native enzyme"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "with o-phenanthroline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0087870:o-phenanthroline [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the extent of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439792:Extent [Spatial Concept]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.204: however, o-phenanthroline did not increase cross-linking with the H112Q mutant. 

Phrase: "however,"

Phrase: "o-phenanthroline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0087870:o-phenanthroline [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "cross-linking with the H112Q mutant."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332220:Cross-linking [Functional Concept]
   773 E C0178576:Cross link [Natural Phenomenon or Process]
   753   C0596988:Mutant [Cell or Molecular Dysfunction]
   753   C2828360:Cross [Conceptual Entity]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]
Processing 00000000.tx.205: Using radioactive zinc, it was concluded that the H112Q mutant did not bind zinc. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "radioactive zinc,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "it"

Phrase: "was"

Phrase: "concluded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "the H112Q mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "zinc."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2348288:Zinc [Element, Ion, or Isotope]
Processing 00000000.tx.206: Our finding that the residual activity of the two His112 mutants, but not the Glu111 mutants, can be further reduced by treatment with metal chelators indicates that these mutants do contain zinc but that the zinc is bound considerably more weakly than with the native protein. 

Phrase: "Our"

Phrase: "finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that"

Phrase: "the residual activity of the two His112 mutants,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the Glu111 mutants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "can"

Phrase: "be"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "reduced by treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C0392756:Reduced [Qualitative Concept]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "with metal chelators"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   983   C1881795:Metal Chelator [Pharmacologic Substance]
   983   C3537172:Metal Chelator [Pharmacologic Substance]
   861   C0007974:Chelators [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827 E C1664784:Chelator [Eukaryote]

Phrase: "indicates"

Phrase: "that"

Phrase: "these mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "do"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "zinc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "but"

Phrase: "that"

Phrase: "the zinc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "is"

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "considerably more weakly than"

Phrase: "with the native protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0302891:Native [Functional Concept]
Processing 00000000.tx.207: Thus, our results with both the His112 and Glu111 mutants support and extend the general conclusions of Perlman and Rosner (37) that mutation of the active site histidine causes a change in the conformation about the active site of IDE. 

Phrase: "Thus,"

Phrase: "our results with both"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "the His112"

Phrase: "and"

Phrase: "Glu111 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "and"

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "the general conclusions of Perlman"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707478:Conclusions [Idea or Concept]

Phrase: "and"

Phrase: "Rosner"

Phrase: "(37"

Phrase: ")"

Phrase: "that mutation of the active site histidine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a change in the conformation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0301641:Conformational change [Molecular Function]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "about the active site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205681:Active Site [Functional Concept]
   861   C0205145:Site [Spatial Concept]
   861   C0205177:Active [Functional Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "of IDE."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.208: The results presented here suggest that this is not due to the loss of zinc binding but probably due to local conformational changes that occur within the active site. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this"

Phrase: "is"

Phrase: "not due to the loss of zinc binding"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0678226:Due to [Functional Concept]
           due
   770   C1148621:zinc binding [Molecular Function]
   744   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1517945:Loss [Quantitative Concept]
   744   C1518422:Not [Functional Concept]
   744   C2348288:Zinc [Element, Ion, or Isotope]
   744   C3146286:Due [Idea or Concept]

Phrase: "but"

Phrase: "probably due to local conformational changes"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0678226:Due to [Functional Concept]
           due
   773   C0301641:Conformational change [Molecular Function]
   753   C0205276:Local [Spatial Concept]
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   753   C0750492:Probably [Idea or Concept]
   753   C3146286:Due [Idea or Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "that"

Phrase: "occur within the active site."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0205681:Active Site [Functional Concept]
   760   C0205145:Site [Spatial Concept]
   760   C0205177:Active [Functional Concept]
   760   C1515974:Site [Body Location or Region]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   760   C2825164:Site [Spatial Concept]
Processing 00000000.tx.209: A rather surprising finding is that mutation of either the catalytic glutamate or the zinc coordinating histidine converts the substrate-velocity curves from sigmoidal to hyperbolic. 

Phrase: "A rather surprising finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037088:Finding [Sign or Symptom]
   827   C0243095:Finding [Finding]
   827   C2825141:Finding [Finding]

Phrase: "is"

Phrase: "that mutation of either"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026882:Mutation [Genetic Function]
   770   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "the catalytic glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "the zinc coordinating histidine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019602:Histidine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "converts"

Phrase: "the substrate-velocity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439830:Velocity [Quantitative Concept]
   861   C1547053:*Velocity [Quantitative Concept]

Phrase: "curves from sigmoidal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205134:Curve [Spatial Concept]

Phrase: "to hyperbolic."
Processing 00000000.tx.210: Thus, the homotropic allosteric activation previously reported by us (35) is absent in the mutants. 

Phrase: "Thus,"

Phrase: "the homotropic allosteric activation previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "reported by us (35"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C1709908:Reported By [Group]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: ")"

Phrase: "is"

Phrase: "absent in the mutants."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:Absent [Quantitative Concept]
   770   C2699517:ABSENT [Finding]
Processing 00000000.tx.211: Since it has been established that IDE can exist in an oligomeric state (32, 35, 50, 51), one possible explanation is that the active site of IDE is at the interface of two subunits and that mutation of the active site residues produces a local conformational change that affects subunit interaction. 

Phrase: "Since"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "can"

Phrase: "exist in an oligomeric state"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C2987476:Exist [Conceptual Entity]
   760   C3148680:State [Geographic Area]

Phrase: "(32,"

Phrase: "35,"

Phrase: "50,"

Phrase: "51"

Phrase: ")"

Phrase: ","

Phrase: "one possible explanation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0681841:Explanation [Intellectual Product]

Phrase: "is"

Phrase: "that"

Phrase: "the active site of IDE"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0205681:Active Site [Functional Concept]
   778   C2945843:Site of [Qualitative Concept]
   748   C0205145:Site [Spatial Concept]
   748   C0205177:Active [Functional Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "is at the interface of two subunits"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205448:Two [Quantitative Concept]
   748   C1708533:Interface [Manufactured Object]
   748   C2698172:Interface [Intellectual Product]
   714   C1711351:Subunit [Quantitative Concept]

Phrase: "and"

Phrase: "that mutation of the active site residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "produces"

Phrase: "a local conformational change"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0301641:Conformational change [Molecular Function]
   827   C0392747:Change [Functional Concept]
   827   C0443172:change [Quantitative Concept]
   827   C1705241:Change [Quantitative Concept]

Phrase: "that"

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "subunit interaction."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.212: This does not appear to be the case, since both we (35) and Perlman et al. 

Phrase: "This"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "since"

Phrase: "both we (35"

Phrase: ")"

Phrase: "and"

Phrase: "Perlman et al."
Processing 00000000.tx.213: (42) have shown that formation of oligomers containing active and inactive subunits does not abrogate activity. 

Phrase: "(42"

Phrase: ")"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that formation of oligomers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "active"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205177:Active [Functional Concept]

Phrase: "and"

Phrase: "inactive subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "abrogate"

Phrase: "activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.214: However, such a mixed oligomer does eliminate allosteric activation (35). 

Phrase: "However,"

Phrase: "such"

Phrase: "a mixed oligomer"

Phrase: "does"

Phrase: "eliminate"

Phrase: "allosteric activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.215: Thus, the data is probably explained by the proposal that the active site mutations produce a local conformational change that is transmitted to the adjacent subunit. 

Phrase: "Thus,"

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "is"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "explained by the proposal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1555306:proposal [Idea or Concept]
   770   C1948033:Proposal [Intellectual Product]

Phrase: "that"

Phrase: "the active site mutations"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0205681:Active Site [Functional Concept]
   827   C0026882:Mutations [Genetic Function]
   827   C0205145:Site [Spatial Concept]
   827   C0205177:Active [Functional Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "produce"

Phrase: "a local conformational"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0026377:Conformation [Spatial Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "transmitted to the adjacent subunit."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0205117:Adjacent to [Spatial Concept]
           Adjacent
   760   C0242781:Transmitted [Pathologic Function]
   760   C0332289:transmitted [Functional Concept]
   760   C1521797:Transmitted [Natural Phenomenon or Process]
   760   C1711351:Subunit [Quantitative Concept]
Processing 00000000.tx.216: Although the end result is the same, it appears that there are differences in the local conformational changes produced by mutating the catalytic glutamate and mutating the zinc-coordinating histidine. 

Phrase: "Although"

Phrase: "the end result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1274040:Result [Functional Concept]
   861   C1546471:Result [Idea or Concept]
   861   C2825142:Result [Finding]

Phrase: "is"

Phrase: "the same,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445247:Same [Qualitative Concept]

Phrase: "it"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "that there"

Phrase: "are"

Phrase: "differences in the local conformational changes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "produced by mutating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1513776:Mutate [Genetic Function]

Phrase: "the catalytic glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "mutating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1513776:Mutate [Genetic Function]

Phrase: "the zinc-coordinating histidine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019602:Histidine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.217: This is most evident from the observation that the cleavage profile for -endorphin is altered in the glutamate mutants but not the histidine mutants. 

Phrase: "This"

Phrase: "is"

Phrase: "most evident from the observation"

Phrase: "that"

Phrase: "the cleavage profile for -endorphin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1979963:Profile [Laboratory Procedure]
   760   C2003903:Profile [Functional Concept]

Phrase: "is"

Phrase: "altered in the glutamate mutants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   760   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0392747:Altered [Functional Concept]
   760   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the histidine mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.218: In addition to the active site mutations affecting the kinetics of substrate binding, these mutations also desensitized the enzyme to activation by triphosphates in the form of ATP or triphosphate itself. 

Phrase: "In addition to the active site mutations"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0205681:Active Site [Functional Concept]
   827   C0026882:Mutations [Genetic Function]
   827   C0205145:Site [Spatial Concept]
   827   C0205177:Active [Functional Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the kinetics of substrate binding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0022702:Kinetics [Natural Phenomenon or Process]
   760   C0220865:kinetics [Functional Concept]
   760   C2825046:Kinetics [Occupation or Discipline]

Phrase: "these mutations also"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "desensitized"

Phrase: "the enzyme to activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0014429:Enzyme Activation [Molecular Function]
   770   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "by triphosphates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0146894:triphosphate [Inorganic Chemical]

Phrase: "in the form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "of ATP"

Phrase: "or"

Phrase: "triphosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0146894:triphosphate [Inorganic Chemical]

Phrase: "itself."
Processing 00000000.tx.219: The large increase in activity seen with the native enzyme was significantly reduced to either no effect or less than a 3-fold increase in activity with the glutamate mutants. 

Phrase: "The large increase in activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "seen with the native enzyme"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0205397:Seen [Qualitative Concept]
   760   C0302891:Native [Functional Concept]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "was"

Phrase: "significantly"

Phrase: "reduced to either"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "no effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "less than a 3-fold increase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0439092:Less Than [Intellectual Product]
           less
   753   C0332462:Fold [Spatial Concept]
   753   C0442805:Increase [Functional Concept]
   753   C0547044:Less [Qualitative Concept]
   753   C1880834:FOLD [Phenomenon or Process]

Phrase: "in activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "with the glutamate mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.220: Even more amazing was the effect seen with the active site histidine mutants, particularly H112Q. 

Phrase: "Even more amazing"

Phrase: "was"

Phrase: "the effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "seen with the active site histidine mutants,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0205681:Active Site [Functional Concept]
   748   C0019602:Histidine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0205145:Site [Spatial Concept]
   748   C0205177:Active [Functional Concept]
   748   C0205397:Seen [Qualitative Concept]
   748   C0596988:mutants [Cell or Molecular Dysfunction]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]
   714 E C0042789:see [Organism Function]
   714 E C1947903:See [Activity]

Phrase: "particularly H112Q."
Processing 00000000.tx.221: In this case, triphosphate changed from an activator to a rather potent inhibitor. 

Phrase: "In this case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "triphosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0146894:triphosphate [Inorganic Chemical]

Phrase: "changed from an activator"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:Changed [Functional Concept]
   770   C0443172:Changed [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "to a rather potent inhibitor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.222: This clearly indicates that the active site of these mutants is conformationally different from the wild type enzyme and is further modulated by additional conformational changes produced by the binding of the triphosphate moiety. 

Phrase: "This clearly"

Phrase: "indicates"

Phrase: "that"

Phrase: "the active site of these mutants"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0205681:Active Site [Functional Concept]
   790   C2945843:Site of [Qualitative Concept]
   753   C0205145:Site [Spatial Concept]
   753   C0205177:Active [Functional Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "conformationally different from the wild type enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "modulated by additional conformational changes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0301641:Conformational change [Molecular Function]
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   760   C0443264:Modulated [Spatial Concept]
   760   C1524062:Additional [Functional Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "produced by the binding of the triphosphate moiety."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0146894:triphosphate [Inorganic Chemical]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
Processing 00000000.tx.223: The sedimentation equilibrium data show that, with the exception of the H112D mutant, both the native enzyme and the mutants are predominantly monomeric. 

Phrase: "The sedimentation equilibrium data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C0597429:sedimentation equilibrium [Natural Phenomenon or Process]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that,"

Phrase: "with the exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1554961:exception [Idea or Concept]
  1000   C1705847:Exception [Conceptual Entity]

Phrase: "of the H112D mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "both"

Phrase: "the native enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "the mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "predominantly monomeric."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0596973:Monomer [Chemical Viewed Structurally]
Processing 00000000.tx.224: Triphosphate does not affect the qualitative oligomerization mechanism of the soluble enzyme, but it increased the tendency to form insoluble aggregates in the case of the E111A and E111F mutants. 

Phrase: "Triphosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0146894:triphosphate [Inorganic Chemical]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the qualitative oligomerization mechanism of the soluble enzyme,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0596524:enzyme mechanism [Molecular Function]
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "but"

Phrase: "it"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the tendency to"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "insoluble aggregates in the case of the E111A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205418:aggregates [Qualitative Concept]

Phrase: "and"

Phrase: "E111F mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.225: Such aggregation may reflect a conformational change due to triphosphate binding. 

Phrase: "Such aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "may"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "a conformational change due to triphosphate binding."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0301641:Conformational change [Molecular Function]
   748   C0392747:Change [Functional Concept]
   748   C0443172:change [Quantitative Concept]
   748   C1705241:Change [Quantitative Concept]
Processing 00000000.tx.226: Thus, there is no obvious correlation between oligomeric state and activity, and the finding of a monomeric native enzyme is not consistent with its allosteric properties. 

Phrase: "Thus,"

Phrase: "there"

Phrase: "is"

Phrase: "no obvious correlation between oligomeric state"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "the finding of a monomeric native enzyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0037088:Finding [Sign or Symptom]
   748   C0243095:Finding [Finding]
   748   C2825141:Finding [Finding]

Phrase: "is"

Phrase: "not consistent with its allosteric properties."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.227: On the other hand, gel filtration shows the native enzyme existing as dimers and tetramers, and at higher protein concentrations dynamic light scattering shows exclusively tetramers. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "gel filtration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0008559:Gel Filtration [Laboratory Procedure]
   861   C0016107:filtration [Laboratory Procedure]
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the native enzyme existing as dimers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C2987476:Exist [Conceptual Entity]

Phrase: "and"

Phrase: "tetramers,"

Phrase: "and at higher protein concentrations dynamic light scattering"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   800   C1882368:Dynamic Light Scattering [Laboratory Procedure]
   770   C0596837:Light Scattering [Phenomenon or Process]
   767   C0670902:LIGHT Protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C0427716:Protein concentration [Laboratory Procedure]
   754   C1304757:Protein concentration [Laboratory or Test Result]
   744   C0023693:Light [Natural Phenomenon or Process]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0086045:Concentrations [Mental Process]
   744   C0439742:Scattering [Spatial Concept]
   744   C0729333:Dynamic [Functional Concept]
   744   C1306462:Light [Functional Concept]
   744   C1515981:And [Idea or Concept]
   744   C1881376:Light [Qualitative Concept]
   711   C0205250:High [Qualitative Concept]
   711   C1299351:High [Qualitative Concept]
   711 E C1446561:Concentration [Quantitative Concept]
   711   C2700149:HIGH [Intellectual Product]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "exclusively tetramers."
Processing 00000000.tx.228: Thus, it is clear that IDE can exist in a number of different oligomerization states. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "is"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "can"

Phrase: "exist in a number of different oligomerization states."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]
   744   C1301808:states [Geographic Area]
   744   C1705242:Different [Qualitative Concept]
   744   C2987476:Exist [Conceptual Entity]
   711 E C1442792:State [Functional Concept]
   711 E C3148680:State [Geographic Area]
Processing 00000000.tx.229: We would suggest that the allosteric kinetics observed can result from substrate induced oligomerization. 

Phrase: "We"

Phrase: "would"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the allosteric kinetics"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022702:Kinetics [Natural Phenomenon or Process]
   861   C0220865:kinetics [Functional Concept]
   861   C2825046:Kinetics [Occupation or Discipline]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "can"

Phrase: "result from substrate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C1710236:Substrate [Manufactured Object]
   790   C2825142:Result [Finding]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "oligomerization."
Processing 00000000.tx.230: In the case of mutant IDE, perhaps an altered local conformational change at the active site is transmitted through the protein such that it prevents the formation of oligomers.  

Phrase: "In the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of mutant IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "perhaps"

Phrase: "an altered local conformational change at the active site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0301641:Conformational change [Molecular Function]
   742   C0392747:Change [Functional Concept]
   742   C0443172:change [Quantitative Concept]
   742   C1705241:Change [Quantitative Concept]

Phrase: "is"

Phrase: "transmitted through the protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0242781:Transmitted [Pathologic Function]
   770   C0332289:transmitted [Functional Concept]
   770   C1521797:Transmitted [Natural Phenomenon or Process]

Phrase: "such"

Phrase: "that"

Phrase: "it"

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "the formation of oligomers."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]
Processing 00000000.tx.231: FOOTNOTES  * This work was supported in part by National Institute of Health Grants DA02243 (to L. B. H.), AG19323 (to L. B. H.), DK54289 (to M. G. F.), and grants from the Alzheimer's Association (to L. B. H.), Fundao de Amparo Pesquisa do Estado de So Paulo FAPESP (to L. J.), Conselho Nacional de Desenvolvimento Cientfico e Tecnolgico (CNPq) (to L. J.), and Human Frontiers for Science Progress Grant RG 00043/2000-M (to L. J.). 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by National Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "of Health Grants DA02243"

Phrase: "("

Phrase: "to L. B. H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C2346686:L/h [Quantitative Concept]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "AG19323"

Phrase: "("

Phrase: "to L. B. H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C2346686:L/h [Quantitative Concept]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "DK54289"

Phrase: "("

Phrase: "to M. G. F."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1306057:M-F [Temporal Concept]
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]
   734   C0456715:m g [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "grants from the Alzheimer's Association"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0018173:Grants [Quantitative Concept]
   726 E C1548284:Grant [Idea or Concept]

Phrase: "("

Phrase: "to L. B. H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C2346686:L/h [Quantitative Concept]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Fundao de Amparo Pesquisa"

Phrase: "do"

Phrase: "Estado de So Paulo FAPESP"

Phrase: "("

Phrase: "to L. J."

Phrase: ")"

Phrase: ","

Phrase: "Conselho Nacional de Desenvolvimento Cientfico e Tecnolgico"

Phrase: "(CNPq"

Phrase: ")"

Phrase: "("

Phrase: "to L. J."

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Human Frontiers for Science Progress Grant RG 00043/2000-"

Phrase: "M (to L. J."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.232: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.233: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.234: Section 1734 solely to indicate this fact.  

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.235: To whom correspondence should be sent: Dept. of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, 800 Rose St., Lexington, KY 40536-0084. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "sent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519246:Sent [Functional Concept]

Phrase: ":"

Phrase: "Dept."

Phrase: "of Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "Cellular Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "College of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0557806:College [Manufactured Object]

Phrase: "University of Kentucky,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022557:Kentucky [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "800 Rose St., Lexington,"

Phrase: "KY 40536-0084."
Processing 00000000.tx.236: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.237: 859-323-5549; 

Phrase: "859-323-5549"

Phrase: ";"
Processing 00000000.tx.238: Fax: 859-323-1727; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "859-323-1727"

Phrase: ";"
Processing 00000000.tx.239: E-mail: lhersh{at}uky.edu . 1 The abbreviations used are: A, amyloid -peptide(s); 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "lhersh{at}uky.edu . 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "A,"

Phrase: "amyloid -peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "s)"

Phrase: ";"
Processing 00000000.tx.240: PPPi, tripolyphosphate; 

Phrase: "PPPi,"

Phrase: "tripolyphosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0146894:tripolyphosphate [Inorganic Chemical]

Phrase: ";"
Processing 00000000.tx.241: AD, Alzheimer disease; 

Phrase: "AD,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.242: IDE, insulin-degrading enzyme; 

Phrase: "IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.243: HPLC, high pressure liquid chromatography; 

Phrase: "HPLC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "high pressure liquid chromatography"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0008562:Chromatography, High Pressure Liquid [Laboratory Procedure]
   861   C0008565:Liquid Chromatography [Laboratory Procedure]
   812   C0008550:Chromatography [Laboratory Procedure]
   812   C0033095:Pressure [Phenomenon or Process]
   812   C0205250:High [Qualitative Concept]
   812   C0302908:Liquid [Substance]
   812   C0460139:Pressure [Finding]
   812   C1299351:High [Qualitative Concept]
   812   C1304698:Liquid [Finding]
   812   C1306345:Pressure [Functional Concept]
   812   C1546699:Liquid NOS [Intellectual Product]
   812   C1561501:Liquid NOS [Substance]
   812   C2700149:HIGH [Intellectual Product]
   712 E C0302647:chromatograph [Medical Device]

Phrase: ";"
Processing 00000000.tx.244: Abz, 2-aminobenzoyl; 

Phrase: "Abz,"

Phrase: "2-aminobenzoyl"

Phrase: ";"
Processing 00000000.tx.245: EDDnp, N-(2,4-dinitrophenyl)ethylenediamine.  

Phrase: "EDDnp,"

Phrase: "N-(2,4-dinitrophenyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "ethylenediamine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015091:Ethylenediamine [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.246: ACKNOWLEDGMENTS  Mass spectral data were obtained at the University of Kentucky Mass Spectrometry Facility or through the Mass Spectrometry Facility at the University of Kentucky Center for Structural Biology. 

Phrase: "ACKNOWLEDGMENTS  Mass spectral data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1511726:Data [Idea or Concept]
   812   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "obtained at the University of Kentucky Mass Spectrometry Facility"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   764   C0037813:Mass Spectrometry [Laboratory Procedure]
   742   C0022557:Kentucky [Geographic Area]
   742   C0041740:University [Manufactured Object,Organization]
   742   C0436196:Spectrometry [Laboratory Procedure]
   742   C0577559:Mass [Finding]
   742   C1301820:Obtained [Functional Concept]
   742   C1306372:*Mass [Quantitative Concept]
   742   C1547538:Facility [Idea or Concept]
   742   C3152252:Mass [Quantitative Concept]
   708 E C1706701:Obtain [Activity]

Phrase: "or through the Mass Spectrometry Facility"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0037813:Mass Spectrometry [Laboratory Procedure]
   753   C0436196:Spectrometry [Laboratory Procedure]
   753   C0577559:Mass [Finding]
   753   C1306372:*Mass [Quantitative Concept]
   753   C1547538:Facility [Idea or Concept]
   753   C3152252:Mass [Quantitative Concept]

Phrase: "at the University of Kentucky Center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205099:Center [Spatial Concept]

Phrase: "for Structural Biology."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0597531:Structural Biology [Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.247: We thank Drs. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Drs."
Processing 00000000.tx.248: Dr. 

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.249: Jack P. 

Phrase: "Jack P."
Processing 00000000.tx.250: Goodman, Haining Zhu, and Xiaoning Lu for assisting with the mass spectral analysis.  

Phrase: "Goodman,"

Phrase: "Haining Zhu,"

Phrase: "and"

Phrase: "Xiaoning Lu for assisting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0024171:LU [Body System]
   770   C0024176:LU [Geographic Area]
   770   C2697939:LU [Quantitative Concept]

Phrase: "with the mass spectral analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1883073:Spectral [Quantitative Concept]
Processing 00000000.tx.251: REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  St. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.252: George-Hyslop, P. 

Phrase: "George-Hyslop,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.253: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.254: (1993) The Molecular Genetics of Alzheimer's Disease, Raven Press, New York Sherrington, R., Rogaev, E. 

Phrase: "(1993"

Phrase: ")"

Phrase: "The Molecular Genetics of Alzheimer's Disease,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]
   783   C0019247:Molecular Disease [Disease or Syndrome]
           genetics disease
   753   C0017398:Genetics [Biomedical Occupation or Discipline]
   753   C0017399:genetics [Biologic Function]
   753   C1521991:Molecular [Qualitative Concept]

Phrase: "Raven Press,"

Phrase: "New York Sherrington,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027976:New York [Geographic Area]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rogaev,"

Phrase: "E."
Processing 00000000.tx.255: I., Liang, Y., Rogaeva, E. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Rogaeva,"

Phrase: "E."
Processing 00000000.tx.256: A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J. 

Phrase: "A.,"

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Chi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720589:Chi [Intellectual Product]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Holman,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tsuda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mar"

Phrase: ","

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Foncin,"

Phrase: "J."
Processing 00000000.tx.257: F., Bruni, A. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Bruni,"

Phrase: "A."
Processing 00000000.tx.258: C., and Montesi, M. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Montesi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.259: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.260: (1995) Nature 375, 754760[CrossRef][Medline] [OrderarticleviaInfotrieve] Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nature 375,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "754760"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Levy-Lahad,"

Phrase: "E.,"

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Romano,"

Phrase: "D."
Processing 00000000.tx.261: M., Oshima, J., Pettingell, W. 

Phrase: "M."

Phrase: ","

Phrase: "Oshima,"

Phrase: "J.,"

Phrase: "Pettingell,"

Phrase: "W."
Processing 00000000.tx.262: H., Yu, C., Jondro, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Jondro,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.263: D., Schmidt, S. 

Phrase: "D."

Phrase: ","

Phrase: "Schmidt,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.264: D., Wang, K., Crowley, A. 

Phrase: "D."

Phrase: ","

Phrase: "Wang,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Crowley,"

Phrase: "A."
Processing 00000000.tx.265: C., Fu, Y. 

Phrase: "C., Fu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016360:FU [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C1424823:FU [Gene or Genome]

Phrase: "Y."
Processing 00000000.tx.266: H., Guenette, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Guenette,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.267: Y., Galas, D., and Nemens, E. 

Phrase: "Y.,"

Phrase: "Galas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0082651:gala [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966   C1439334:GALA [Gene or Genome]

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Nemens,"

Phrase: "E."
Processing 00000000.tx.268: (1995) Science 269, 973977[Medline] [OrderarticleviaInfotrieve] Rogaev, E. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Science 269,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "973977"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Rogaev,"

Phrase: "E."
Processing 00000000.tx.269: I., Sherrington, R., Rogaeva, E. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rogaeva,"

Phrase: "E."
Processing 00000000.tx.270: A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., Mar, L., Sorbi, S., Nacmias, B., Piacentini, S., and Amaducci, L. 

Phrase: "A.,"

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Chi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720589:Chi [Intellectual Product]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Holman,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tsuda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mar"

Phrase: ","

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Sorbi,"

Phrase: "S."

Phrase: ","

Phrase: "Nacmias,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Piacentini,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Amaducci,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.271: (1995) Nature 376, 775778[CrossRef][Medline] [OrderarticleviaInfotrieve] Leissring, M. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nature 376,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "775778"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Leissring,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.272: A., Lu, A., Condron, M. 

Phrase: "A.,"

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "A.,"

Phrase: "Condron,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.273: M., Teplow, D. 

Phrase: "M."

Phrase: ","

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.274: B., Stein, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Stein,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.275: L., Farris, W., and Selkoe, D.J. 

Phrase: "L., Farris,"

Phrase: "W.,"

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.276: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.277: Biol. 

Phrase: "Biol."
Processing 00000000.tx.278: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.279: 278, 3731437320[Abstract/Free FullText] Fukumoto, H., Cheung, B.S., Hyman, B. 

Phrase: "278,"

Phrase: "3731437320"

Phrase: "[Abstract/Free FullText"

Phrase: "] Fukumoto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Cheung,"

Phrase: "B.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.280: T., and Irizarry, M. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Irizarry,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.281: C. 

Phrase: "C."
Processing 00000000.tx.282: (2002) Arch. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.283: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.284: 59, 13811389[Abstract/Free FullText] Yang, L. 

Phrase: "59,"

Phrase: "13811389"

Phrase: "[Abstract/Free FullText"

Phrase: "] Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.285: B., Lindholm, K., Yan, R., Citron, M., Xia, W., Yang, X. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Lindholm,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yan,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Xia,"

Phrase: "W.,"

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "X."
Processing 00000000.tx.286: L., Beach, T., Sue, L., Wong, P., Price, D., Li, R., and Shen, Y. 

Phrase: "L., Beach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0331781:Beach [Geographic Area]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sue"

Phrase: ","

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Wong,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Shen,"

Phrase: "Y."
Processing 00000000.tx.287: (2003) Nat. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.288: Med. 

Phrase: "Med."
Processing 00000000.tx.289: 9, 34[CrossRef][Medline] [OrderarticleviaInfotrieve] Li, R., Lindholm, K., Yang, L. 

Phrase: "9,"

Phrase: "34"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lindholm,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.290: B., Yue, X., Citron, M., Yan, R., Beach, T., Sue, L., Sabbagh, M., Cai, H., Wong, P., Price, D., and Shen Y. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Yue,"

Phrase: "X.,"

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Yan,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Beach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331781:Beach [Geographic Area]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sue"

Phrase: ","

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Sabbagh,"

Phrase: "M."

Phrase: ","

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wong,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Shen Y."
Processing 00000000.tx.291: (2004) Proc. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.292: Natl. 

Phrase: "Natl."
Processing 00000000.tx.293: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.294: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.295: U. 

Phrase: "U."
Processing 00000000.tx.296: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.297: A. 

Phrase: "A."
Processing 00000000.tx.298: 101, 36323637[Abstract/Free FullText] DeMattos, R. 

Phrase: "101,"

Phrase: "36323637"

Phrase: "[Abstract/Free FullText"

Phrase: "] DeMattos,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.299: B., Bales, K. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Bales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2826220:BALE [Quantitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.300: R., Cummins, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Cummins,"

Phrase: "D."
Processing 00000000.tx.301: J., Dodart, J. 

Phrase: "J.,"

Phrase: "Dodart,"

Phrase: "J."
Processing 00000000.tx.302: C., Paul, S. 

Phrase: "C., Paul,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.303: M., and Holtzman, D. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Holtzman,"

Phrase: "D."
Processing 00000000.tx.304: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.305: (2001) Proc. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.306: Natl. 

Phrase: "Natl."
Processing 00000000.tx.307: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.308: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.309: U. 

Phrase: "U."
Processing 00000000.tx.310: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.311: A. 

Phrase: "A."
Processing 00000000.tx.312: 98, 88508855[Abstract/Free FullText] DeMattos, R. 

Phrase: "98,"

Phrase: "88508855"

Phrase: "[Abstract/Free FullText"

Phrase: "] DeMattos,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.313: B., Bales, K. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Bales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2826220:BALE [Quantitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.314: R., Cummins, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Cummins,"

Phrase: "D."
Processing 00000000.tx.315: J., Paul, S. 

Phrase: "J.,"

Phrase: "Paul,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.316: M., and Holtzman, D. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Holtzman,"

Phrase: "D."
Processing 00000000.tx.317: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.318: (2002) Science 295, 22642267[Abstract/Free FullText] Zlokovic, B. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Science 295,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "22642267"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zlokovic,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.319: V. 

Phrase: "V."
Processing 00000000.tx.320: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.321: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.322: 89, 807811[CrossRef][Medline] [OrderarticleviaInfotrieve] Qiu, W. 

Phrase: "89,"

Phrase: "807811"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Qiu,"

Phrase: "W."
Processing 00000000.tx.323: Q., Ye, Z., Kholodenko, D., Seubert, P., and Selkoe, D. 

Phrase: "Q., Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043402:YE [Geographic Area]

Phrase: "Z.,"

Phrase: "Kholodenko,"

Phrase: "D."

Phrase: ","

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.324: J. 

Phrase: "J."
Processing 00000000.tx.325: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.326: Biol. 

Phrase: "Biol."
Processing 00000000.tx.327: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.328: 272, 66416646[Abstract/Free FullText] Mukherjee, A., and Hersh, L. 

Phrase: "272,"

Phrase: "66416646"

Phrase: "[Abstract/Free FullText"

Phrase: "] Mukherjee,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Hersh,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.329: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.330: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.331: Alzheimers Dis. 

Phrase: "Alzheimers Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0451119:DIS [Intellectual Product]
   861   C1444662:DIS [Finding]
Processing 00000000.tx.332: 4, 341348[Medline] [OrderarticleviaInfotrieve] Hersh, L. 

Phrase: "4,"

Phrase: "341348"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hersh,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.333: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.334: (2003) Curr. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.335: Pharm. 

Phrase: "Pharm."
Processing 00000000.tx.336: Des. 

Phrase: "Des."
Processing 00000000.tx.337: 9, 449454[CrossRef][Medline] [OrderarticleviaInfotrieve] Carson, J. 

Phrase: "9,"

Phrase: "449454"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Carson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551667:Carson [Population Group]

Phrase: "J."
Processing 00000000.tx.338: A., and Turner, A. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Turner,"

Phrase: "A."
Processing 00000000.tx.339: J. 

Phrase: "J."
Processing 00000000.tx.340: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.341: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.342: 81, 18[CrossRef][Medline] [OrderarticleviaInfotrieve] Iwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., Kawashima-Morishima, M., Lee, H. 

Phrase: "81,"

Phrase: "18"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Iwata,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Tsubuki,"

Phrase: "S."

Phrase: ","

Phrase: "Takaki,"

Phrase: "Y.,"

Phrase: "Watanabe,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sekiguchi,"

Phrase: "M."

Phrase: ","

Phrase: "Hosoki,"

Phrase: "E.,"

Phrase: "Kawashima-Morishima,"

Phrase: "M."

Phrase: ","

Phrase: "Lee,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.343: J., Hama, E., Sekine-Aizawa, Y., and Saido, T. 

Phrase: "J.,"

Phrase: "Hama,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1291910:HAMA [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1295018:HAMA [Laboratory Procedure]
  1000   C3541258:HAMA [Intellectual Product]

Phrase: "E.,"

Phrase: "Sekine-Aizawa,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.344: C. 

Phrase: "C."
Processing 00000000.tx.345: (2000) Nat. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.346: Med. 

Phrase: "Med."
Processing 00000000.tx.347: 6, 143150[CrossRef][Medline] [OrderarticleviaInfotrieve] Marr, R. 

Phrase: "6,"

Phrase: "143150"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Marr,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.348: A., Guan, H., Rockenstein, E., Kindy, M., Gage, F. 

Phrase: "A.,"

Phrase: "Guan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325602:Guan [Bird]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rockenstein,"

Phrase: "E.,"

Phrase: "Kindy,"

Phrase: "M."

Phrase: ","

Phrase: "Gage,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456564:Gauge [Spatial Concept]
  1000   C1521879:GAGE [Immunologic Factor]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.349: H., Verma, I., Masliah, E., and Hersh, L. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Verma,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Hersh,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.350: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.351: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.352: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.353: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.354: 22, 512[CrossRef][Medline] [OrderarticleviaInfotrieve] Miller, B. 

Phrase: "22,"

Phrase: "512"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.355: C., Eckman, E. 

Phrase: "C., Eckman,"

Phrase: "E."
Processing 00000000.tx.356: A., Sambamurti, K., Dobbs, N., Chow, K. 

Phrase: "A.,"

Phrase: "Sambamurti,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Dobbs,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Chow,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0324335:chow [Mammal]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.357: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.358: Eckman, C. 

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.359: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.360: Hersh, L. 

Phrase: "Hersh,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.361: B., and Thiele, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Thiele,"

Phrase: "D."
Processing 00000000.tx.362: L., (2003) Proc. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "(2003"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.363: Natl. 

Phrase: "Natl."
Processing 00000000.tx.364: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.365: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.366: U. 

Phrase: "U."
Processing 00000000.tx.367: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.368: A. 

Phrase: "A."
Processing 00000000.tx.369: 100, 62216226[Abstract/Free FullText] Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E.A., Frosch, M.P., Eckman, C. 

Phrase: "100,"

Phrase: "62216226"

Phrase: "[Abstract/Free FullText"

Phrase: "] Farris,"

Phrase: "W.,"

Phrase: "Mansourian,"

Phrase: "S."

Phrase: ","

Phrase: "Chang,"

Phrase: "Y.,"

Phrase: "Lindsley,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "E.A.,"

Phrase: "Frosch,"

Phrase: "M."

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.370: B., Tanzi, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.371: E., Selkoe, D. 

Phrase: "E.,"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.372: J., and Guenette, S. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Guenette,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.373: (2003) Proc. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.374: Natl. 

Phrase: "Natl."
Processing 00000000.tx.375: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.376: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.377: U. 

Phrase: "U."
Processing 00000000.tx.378: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.379: A. 

Phrase: "A."
Processing 00000000.tx.380: 100, 41624167[Abstract/Free FullText] Eckman, E. 

Phrase: "100,"

Phrase: "41624167"

Phrase: "[Abstract/Free FullText"

Phrase: "] Eckman,"

Phrase: "E."
Processing 00000000.tx.381: A., Reed, D. 

Phrase: "A.,"

Phrase: "Reed,"

Phrase: "D."
Processing 00000000.tx.382: K., and Eckman, C. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.383: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.384: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.385: Biol. 

Phrase: "Biol."
Processing 00000000.tx.386: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.387: 276, 2454024548[Abstract/Free FullText] Eckman, E. 

Phrase: "276,"

Phrase: "2454024548"

Phrase: "[Abstract/Free FullText"

Phrase: "] Eckman,"

Phrase: "E."
Processing 00000000.tx.388: A., Watson, M., Marlow, L., Sambamurti, K., and Eckman, C. 

Phrase: "A.,"

Phrase: "Watson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3476816:Watson [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Marlow,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Sambamurti,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.389: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.390: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.391: Biol. 

Phrase: "Biol."
Processing 00000000.tx.392: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.393: 278, 20812084[Abstract/Free FullText] Bertram, L., Blacker, D., Mullin, K., Keeney, D., Jones, J., Basu, S., Yhu, S., McInnis, M. 

Phrase: "278,"

Phrase: "20812084"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bertram,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Blacker,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0005680:Black [Population Group]
   966   C0027567:Black [Population Group]
   966   C0085756:Black [Population Group]
   966   C0439541:Black [Qualitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Mullin,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Keeney,"

Phrase: "D."

Phrase: ","

Phrase: "Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "J.,"

Phrase: "Basu,"

Phrase: "S."

Phrase: ","

Phrase: "Yhu,"

Phrase: "S."

Phrase: ","

Phrase: "McInnis,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.394: G., Go, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: ","

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.395: C., Vekrellis, K., Selkoe, D. 

Phrase: "C., Vekrellis,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.396: J., Saunders, A. 

Phrase: "J.,"

Phrase: "Saunders,"

Phrase: "A."
Processing 00000000.tx.397: J., and Tanzi, R. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.398: E. 

Phrase: "E."
Processing 00000000.tx.399: (2000) Science 290, 23022303[Abstract/Free FullText] Ertekin-Taner, N., Graff-Radford, N., Younkin, L. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Science 290,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "23022303"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ertekin-Taner,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Graff-Radford,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Younkin,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.400: H., Eckman, C., Baker. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Baker."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]
Processing 00000000.tx.401: M., Adamson, J., Ronald, J., Blangero, J., Hutton, M., Younkin, S. 

Phrase: "M."

Phrase: ","

Phrase: "Adamson,"

Phrase: "J.,"

Phrase: "Ronald,"

Phrase: "J.,"

Phrase: "Blangero,"

Phrase: "J.,"

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.402: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.403: (2000) Science 290, 23032304[Abstract/Free FullText] Ertekin-Taner, N., Allen, M., Fadale, D., Scanlin, L., Younkin, L., Petersen, R. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Science 290,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "23032304"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ertekin-Taner,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Allen,"

Phrase: "M."

Phrase: ","

Phrase: "Fadale,"

Phrase: "D."

Phrase: ","

Phrase: "Scanlin,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Younkin,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Petersen,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.404: C., Graff-Radford, N., and Younkin, S. 

Phrase: "C., Graff-Radford,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.405: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.406: (2004) Hum. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Hum."
Processing 00000000.tx.407: Mutat. 

Phrase: "Mutat."
Processing 00000000.tx.408: 23, 334342[CrossRef][Medline] [OrderarticleviaInfotrieve] Myers, A., Holmans, P., Marshall, H., Kwon, J., Meyer, D., Ramic, D., Shears, S., Booth, J., DeVrieze, F. 

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "334342"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Myers,"

Phrase: "A.,"

Phrase: "Holmans,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Marshall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551881:Marshall [Population Group]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kwon,"

Phrase: "J.,"

Phrase: "Meyer,"

Phrase: "D."

Phrase: ","

Phrase: "Ramic,"

Phrase: "D."

Phrase: ","

Phrase: "Shears,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0175735:shears [Medical Device]
   966 E C0205013:shear [Therapeutic or Preventive Procedure]

Phrase: "S."

Phrase: ","

Phrase: "Booth,"

Phrase: "J.,"

Phrase: "DeVrieze,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.409: W., Crook, R., Hamshere, M., Abraham, R., Tunstall, N., Rice, F., Carty, S., Lillystone, S., Kehoe, P., Rudrasingham, V., Jones, L., Lovestone, S., Perez-Tur, J., Williams, J., Owen, M. 

Phrase: "W., Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hamshere,"

Phrase: "M."

Phrase: ","

Phrase: "Abraham,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442982:Abraham [Intellectual Product]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tunstall,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Rice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035567:Rice [Food]
  1000   C1140671:rice [Plant]
  1000   C1509547:RICE [Organic Chemical,Pharmacologic Substance]
  1000   C3484401:RICE [Pharmacologic Substance]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Carty,"

Phrase: "S."

Phrase: ","

Phrase: "Lillystone,"

Phrase: "S."

Phrase: ","

Phrase: "Kehoe,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Rudrasingham,"

Phrase: "V.,"

Phrase: "Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Lovestone,"

Phrase: "S."

Phrase: ","

Phrase: "Perez-Tur,"

Phrase: "J.,"

Phrase: "Williams,"

Phrase: "J.,"

Phrase: "Owen,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.410: J., Hardy, J., Goate, A. 

Phrase: "J.,"

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Goate,"

Phrase: "A."
Processing 00000000.tx.411: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.412: (2000) Science 290, 23042305[Abstract/Free FullText] Duckworth, W. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Science 290,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "23042305"

Phrase: "[Abstract/Free FullText"

Phrase: "] Duckworth,"

Phrase: "W."
Processing 00000000.tx.413: C., Bennett, R. 

Phrase: "C., Bennett,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.414: G., and Hamel, F. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Hamel,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.415: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.416: (1998) Endocr. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Endocr."
Processing 00000000.tx.417: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.418: 19, 608624[Abstract/Free FullText] Seta, K. 

Phrase: "19,"

Phrase: "608624"

Phrase: "[Abstract/Free FullText"

Phrase: "] Seta,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.419: A., and Roth, R. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Roth,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.420: A. 

Phrase: "A."
Processing 00000000.tx.421: (1997) Biochem. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.422: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.423: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.424: Commun. 

Phrase: "Commun."
Processing 00000000.tx.425: 231, 167171[CrossRef][Medline] [OrderarticleviaInfotrieve] Vekrellis, K., Ye, Z., Qiu, W. 

Phrase: "231,"

Phrase: "167171"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Vekrellis,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043402:YE [Geographic Area]

Phrase: "Z.,"

Phrase: "Qiu,"

Phrase: "W."
Processing 00000000.tx.426: Q., Walsh, D., Hartley, D., Chesneau, V., Rosner, M. 

Phrase: "Q., Walsh,"

Phrase: "D."

Phrase: ","

Phrase: "Hartley,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0324525:Hartley [Mammal]

Phrase: "D."

Phrase: ","

Phrase: "Chesneau,"

Phrase: "V.,"

Phrase: "Rosner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.427: R., and Selkoe, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.428: J. 

Phrase: "J."
Processing 00000000.tx.429: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.430: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.431: 20, 16571665[Abstract/Free FullText] Qiu, W., Q., Walsh, D. 

Phrase: "20,"

Phrase: "16571665"

Phrase: "[Abstract/Free FullText"

Phrase: "] Qiu,"

Phrase: "W.,"

Phrase: "Q.,"

Phrase: "Walsh,"

Phrase: "D."
Processing 00000000.tx.432: M., Ye, Z., Vekrellis, K., Zhang, J., Podlisny, M. 

Phrase: "M."

Phrase: ","

Phrase: "Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043402:YE [Geographic Area]

Phrase: "Z.,"

Phrase: "Vekrellis,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Zhang,"

Phrase: "J.,"

Phrase: "Podlisny,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.433: B., Rosner, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Rosner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.434: R., Safavi, A., Hersh, L. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Safavi,"

Phrase: "A.,"

Phrase: "Hersh,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.435: B., and Selkoe, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.436: J. 

Phrase: "J."
Processing 00000000.tx.437: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.438: Biol. 

Phrase: "Biol."
Processing 00000000.tx.439: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.440: 273, 3273032738[Abstract/Free FullText] Farris, W., Mansourian, S., Leissring, M. 

Phrase: "273,"

Phrase: "3273032738"

Phrase: "[Abstract/Free FullText"

Phrase: "] Farris,"

Phrase: "W.,"

Phrase: "Mansourian,"

Phrase: "S."

Phrase: ","

Phrase: "Leissring,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.441: A., Eckman, E. 

Phrase: "A.,"

Phrase: "Eckman,"

Phrase: "E."
Processing 00000000.tx.442: A., Bertram, L., Eckman, C. 

Phrase: "A.,"

Phrase: "Bertram,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.443: B., Tanzi, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.444: E., and Selkoe, D. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.445: J. 

Phrase: "J."
Processing 00000000.tx.446: (2004) Am. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.447: J. 

Phrase: "J."
Processing 00000000.tx.448: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.449: 164, 14251434[Abstract/Free FullText] Authier, F., Posner, B. 

Phrase: "164,"

Phrase: "14251434"

Phrase: "[Abstract/Free FullText"

Phrase: "] Authier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Posner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.450: I., and Bergeron, J. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Bergeron,"

Phrase: "J."
Processing 00000000.tx.451: J. 

Phrase: "J."
Processing 00000000.tx.452: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.453: (1996) Clin. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.454: Invest. 

Phrase: "Invest."
Processing 00000000.tx.455: Med. 

Phrase: "Med."
Processing 00000000.tx.456: 19, 149160[Medline] [OrderarticleviaInfotrieve] Safavi, A., Miller, B. 

Phrase: "19,"

Phrase: "149160"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Safavi,"

Phrase: "A.,"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.457: C., Cottam, L., and Hersh, L. 

Phrase: "C., Cottam,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Hersh,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.458: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.459: (1996) Biochemistry 35, 1431814325[CrossRef][Medline] [OrderarticleviaInfotrieve] Kurochkin, I. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Biochemistry 35,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "1431814325"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kurochkin,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.460: V. 

Phrase: "V."
Processing 00000000.tx.461: (2001) Trends Biochem. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem."
Processing 00000000.tx.462: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.463: 26, 421425[CrossRef][Medline] [OrderarticleviaInfotrieve] Mukherjee, A., Song, E. 

Phrase: "26,"

Phrase: "421425"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mukherjee,"

Phrase: "A.,"

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "E."
Processing 00000000.tx.464: S., Kihiko, M., Goodman, J. 

Phrase: "S."

Phrase: ","

Phrase: "Kihiko,"

Phrase: "M."

Phrase: ","

Phrase: "Goodman,"

Phrase: "J."
Processing 00000000.tx.465: P., Jr., Pyrek, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Pyrek,"

Phrase: "J."
Processing 00000000.tx.466: S., Estus, S., and Hersh, L. 

Phrase: "S."

Phrase: ","

Phrase: "Estus,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Hersh,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.467: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.468: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.469: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.470: 20, 87458749[Abstract/Free FullText] Song, E. 

Phrase: "20,"

Phrase: "87458749"

Phrase: "[Abstract/Free FullText"

Phrase: "] Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "E."
Processing 00000000.tx.471: S., Juliano, M. 

Phrase: "S."

Phrase: ","

Phrase: "Juliano,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.472: A., Juliano, L., and Hersh, L. 

Phrase: "A.,"

Phrase: "Juliano,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Hersh,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.473: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.474: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.475: Biol. 

Phrase: "Biol."
Processing 00000000.tx.476: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.477: 278, 4978949794[Abstract/Free FullText] Csuhai, E., Juliano, M. 

Phrase: "278,"

Phrase: "4978949794"

Phrase: "[Abstract/Free FullText"

Phrase: "] Csuhai,"

Phrase: "E.,"

Phrase: "Juliano,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.478: A., Pyrek, J. 

Phrase: "A.,"

Phrase: "Pyrek,"

Phrase: "J."
Processing 00000000.tx.479: S., Harms, A. 

Phrase: "S."

Phrase: ","

Phrase: "Harms,"

Phrase: "A."
Processing 00000000.tx.480: C., Juliano, L., and Hersh, L. 

Phrase: "C., Juliano,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Hersh,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.481: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.482: (1999) Anal. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.483: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.484: 269, 149154[CrossRef][Medline] [OrderarticleviaInfotrieve] Perlman, R. 

Phrase: "269,"

Phrase: "149154"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Perlman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.485: K., and Rosner, M. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Rosner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.486: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.487: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.488: Biol. 

Phrase: "Biol."
Processing 00000000.tx.489: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.490: 269, 3314033146[Abstract/Free FullText] Rost, B. 

Phrase: "269,"

Phrase: "3314033146"

Phrase: "[Abstract/Free FullText"

Phrase: "] Rost,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.491: (1996) Methods Enzymol. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.492: 266, 525539[CrossRef][Medline] [OrderarticleviaInfotrieve] Rost, B., and Sander, C. 

Phrase: "266,"

Phrase: "525539"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Rost,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Sander,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1504648:Sander [Fish]

Phrase: "C."
Processing 00000000.tx.493: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.494: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.495: Biol. 

Phrase: "Biol."
Processing 00000000.tx.496: 232, 584599[CrossRef][Medline] [OrderarticleviaInfotrieve] Cohn, E. 

Phrase: "232,"

Phrase: "584599"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Cohn,"

Phrase: "E."
Processing 00000000.tx.497: J., and Edsall, J. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Edsall,"

Phrase: "J."
Processing 00000000.tx.498: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.499: (1943) Proteins, Amino Acids and Peptides as Ions and Dipolar Ions, pp. 

Phrase: "(1943"

Phrase: ")"

Phrase: "Proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Amino Acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "Peptides as Ions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "Dipolar Ions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0022023:Ions [Element, Ion, or Isotope]
   827 E C1700702:ION [Functional Concept]

Phrase: "pp."
Processing 00000000.tx.500: 370381, Reinhold, New York Johnson, M. 

Phrase: "370381,"

Phrase: "Reinhold,"

Phrase: "New York Johnson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027976:New York [Geographic Area]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.501: L., Correia, J. 

Phrase: "L., Correia,"

Phrase: "J."
Processing 00000000.tx.502: J., Yphantis, D. 

Phrase: "J.,"

Phrase: "Yphantis,"

Phrase: "D."
Processing 00000000.tx.503: A., and Halvorson, H. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Halvorson,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.504: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.505: (1981) Biophys. 

Phrase: "(1981"

Phrase: ")"

Phrase: "Biophys."
Processing 00000000.tx.506: J. 

Phrase: "J."
Processing 00000000.tx.507: 36, 575588[Abstract] Perlman, R. 

Phrase: "36,"

Phrase: "575588"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Perlman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.508: K., Gehm, B. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gehm,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.509: D., Kuo, W. 

Phrase: "D."

Phrase: ","

Phrase: "Kuo,"

Phrase: "W."
Processing 00000000.tx.510: L., and Rosner, M. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Rosner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.511: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.512: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.513: Biol. 

Phrase: "Biol."
Processing 00000000.tx.514: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.515: 268, 2153821544[Abstract/Free FullText] Thompson, M. 

Phrase: "268,"

Phrase: "2153821544"

Phrase: "[Abstract/Free FullText"

Phrase: "] Thompson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.516: W., Govindaswami, M., and Hersh, L. 

Phrase: "W., Govindaswami,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Hersh,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.517: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.518: (2003) Arch. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.519: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.520: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.521: 413, 236242[CrossRef][Medline] [OrderarticleviaInfotrieve] Song, E.S., Juliano, M. 

Phrase: "413,"

Phrase: "236242"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "E.S.,"

Phrase: "Juliano,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.522: A., Juliano, L., Fried, M. 

Phrase: "A.,"

Phrase: "Juliano,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Fried,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1825319:FRY [Gene or Genome]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.523: G., Wagner, S. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Wagner,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.524: L., and Hersh, L. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Hersh,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.525: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.526: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.527: Biol. 

Phrase: "Biol."
Processing 00000000.tx.528: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.529: 279, 5421654220[Abstract/Free FullText] Devault, A., Nault, C., Zollinger, M., Fournie-Zaluski, M. 

Phrase: "279,"

Phrase: "5421654220"

Phrase: "[Abstract/Free FullText"

Phrase: "] Devault,"

Phrase: "A.,"

Phrase: "Nault,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Zollinger,"

Phrase: "M."

Phrase: ","

Phrase: "Fournie-Zaluski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.530: C., Roques, B. 

Phrase: "C., Roques,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.531: P., Crine, P., and Boileau, G. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Crine,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Boileau,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.532: (1988) J. 

Phrase: "(1988"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.533: Biol. 

Phrase: "Biol."
Processing 00000000.tx.534: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.535: 263, 40334040[Abstract/Free FullText] Wetterholm, A., Medina, J. 

Phrase: "263,"

Phrase: "40334040"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wetterholm,"

Phrase: "A.,"

Phrase: "Medina,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2767010:Medina [Eukaryote]

Phrase: "J."
Processing 00000000.tx.536: F., Radmark, O., Shapiro, R., Haeggstrom, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Radmark,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Shapiro,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Haeggstrom,"

Phrase: "J."
Processing 00000000.tx.537: Z., Vallee, B. 

Phrase: "Z.,"

Phrase: "Vallee,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.538: L., and Samuelsson, B. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Samuelsson,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.539: (1992) Proc. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.540: Natl. 

Phrase: "Natl."
Processing 00000000.tx.541: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.542: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.543: U. 

Phrase: "U."
Processing 00000000.tx.544: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.545: A. 

Phrase: "A."
Processing 00000000.tx.546: 89, 91419145[Abstract/Free FullText] Vazeux, G., Wang, J., Corvol, P., and Llorens-Cortes, C. 

Phrase: "89,"

Phrase: "91419145"

Phrase: "[Abstract/Free FullText"

Phrase: "] Vazeux,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Wang,"

Phrase: "J.,"

Phrase: "Corvol,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Llorens-Cortes,"

Phrase: "C."
Processing 00000000.tx.547: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.548: Biol. 

Phrase: "Biol."
Processing 00000000.tx.549: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.550: 271, 90699074[Abstract/Free FullText] Cha, J., and Auld, D. 

Phrase: "271,"

Phrase: "90699074"

Phrase: "[Abstract/Free FullText"

Phrase: "] Cha,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420648:CHA [Gene or Genome]

Phrase: "J.,"

Phrase: "and"

Phrase: "Auld,"

Phrase: "D."
Processing 00000000.tx.551: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.552: (1997) Biochemistry 36, 1601916024[CrossRef][Medline] [OrderarticleviaInfotrieve] Kubo, M., Mitsuda, Y., Takagi, M., and Imanaka, T. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Biochemistry 36,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "1601916024"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kubo,"

Phrase: "M."

Phrase: ","

Phrase: "Mitsuda,"

Phrase: "Y.,"

Phrase: "Takagi,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Imanaka,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.553: (1992) Appl. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Appl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1858559:APPL [Gene or Genome]
Processing 00000000.tx.554: Environ. 

Phrase: "Environ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1568941:Environ [Organic Chemical]
Processing 00000000.tx.555: Microbiol. 

Phrase: "Microbiol."
Processing 00000000.tx.556: 58, 37793783[Abstract] Ding, L., Becker, A. 

Phrase: "58,"

Phrase: "37793783"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ding,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419419:DING [Gene or Genome]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Becker,"

Phrase: "A."
Processing 00000000.tx.557: B., Suzuki, A., and Roth, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "A.,"

Phrase: "and"

Phrase: "Roth,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.558: A. 

Phrase: "A."
Processing 00000000.tx.559: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.560: Biol. 

Phrase: "Biol."
Processing 00000000.tx.561: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.562: 267, 24142420[Abstract/Free FullText] Shii, K., Yokono, K., Baba, S., and Roth, R. 

Phrase: "267,"

Phrase: "24142420"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shii,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yokono,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Baba,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Roth,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.563: A. 

Phrase: "A."
Processing 00000000.tx.564: (1986) Diabetes 36, 675683 This Article Abstract Full Text (PDF) All Versions of this Article: 280/18/17701 most recent M501896200v1 Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Permissions Google Scholar Articles by Song, E. 

Phrase: "(1986"

Phrase: ")"

Phrase: "Diabetes 36,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "675683"

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "280/18/17701 most recent M501896200v1 Purchase Article View Shopping Cart"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   801   C0441061:Shopping cart [Manufactured Object]
   788   C0179636:Cart [Manufactured Object]
   788   C1824528:CART [Gene or Genome]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Citation Map Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0557854:Services [Occupational Activity]
   793 E C2825316:Service [Manufactured Object]
   793 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal Download"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0162443:Journal [Intellectual Product,Manufactured Object]
   744   C0205314:New [Temporal Concept]
   711   C0033213:Issue [Finding]
   711   C1706387:Issue [Intellectual Product]

Phrase: "to citation manager Copyright Permissions Google Scholar Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C1706852:Article [Intellectual Product]

Phrase: "by Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "E."
Processing 00000000.tx.565: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.566: Articles by Hersh, L. 

Phrase: "Articles by Hersh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.567: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.568: Articles citing this Article PubMed PubMed Citation Articles by Song, E. 

Phrase: "Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706852:Article [Intellectual Product]

Phrase: "citing"

Phrase: "this Article PubMed PubMed Citation Articles by Song,"

Phrase: "E."
Processing 00000000.tx.569: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.570: Articles by Hersh, L. 

Phrase: "Articles by Hersh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.571: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.572: HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS All ASBMB Journals Molecular and Cellular Proteomics Journal of Lipid Research Biochemistry and Molecular Biology Education Copyright  2005 by the American Society for Biochemistry and Molecular Biology.

Phrase: "HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0039224:Table [Manufactured Object]
   742   C1706073:Table [Medical Device]
   742   C1706074:Table [Intellectual Product]

Phrase: "All ASBMB Journals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0162443:journals [Intellectual Product,Manufactured Object]

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "Cellular Proteomics Journal of Lipid Research Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "and"

Phrase: "Molecular Biology Education Copyright  2005 by the American Society"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   742   C0005532:Biology [Biomedical Occupation or Discipline]
   742   C0009993:Copyright [Intellectual Product]
   742   C0013621:Education [Educational Activity]
   742   C0013622:education [Classification]
   742   C0013658:Education, NOS [Finding]
   742   C0037455:society [Organization]
   742   C0039401:Education [Educational Activity]
   742   C0596070:American [Population Group]
   742   C1521991:Molecular [Qualitative Concept]
   742   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

